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Summary 
Glutaredoxins (Grxs) are small ubiquitous oxidoreductases. Trypanosoma 
brucei, the causative of African sleeping sickness, contains two dithiol 
glutaredoxins. Previous studies had shown that RNA interference against Grx2 
resulted in a proliferation defect of the procyclic insect form whilst depletion 
of Grx1 did not show any phenotype in both the mammalian bloodstream and 
procyclic cells.  
The aim of my thesis was to investigate the physiological roles of Grx1 and 
Grx2 in more detail. For this purpose, I generated bloodstream cell lines lacking 
both alleles of Grx1 or Grx2. Under normal culture conditions, the mutant cells 
did not show any growth defect, however, remarkably, displayed an improved 
proliferation compared to wildtype cells when cultured at elevated 
temperature. Immunofluorescence microscopy of DAPI-stained cells showed in 
the wildtype population a significantly higher proportion of parasites with at 
least two kinetoplasts and two nuclei when compared to the knockout cell 
lines. The two glutaredoxins cannot substitute for each other. In bloodstream 
cells there was no upregulation of either protein when the other one was 
absent. Treatment of recombinant Grx1 with GSH/diamide resulted in the 
glutathionylation of its non-active site third cysteine accompanied by a three-
fold decrease in activity to reduce glutathione-mixed disulfides. Procyclic Grx1-
deficient cells could also be obtained. The protein proved to be dispensable 
even in the presence of different stresses. However, in the case of Grx2, the 
second allele could only be replaced in cells possessing an inducible ectopic 
copy of either wildtype or C34S Grx2, but not the C31S/C34S mutant. Both 
types of cell lines displayed leaky expression of the ectopic copy when the 
second grx2 allele was knocked out, suggesting an essential role for this 
protein in procyclic cells as the system was tightly controlled in parasites still 
having one grx2 allele. These results show that Grx2 has a redox function in 
procyclic cells requiring at least the N-terminal active site cysteine. In vitro 
assays with wildtype and C34S Grx2 suggested that the protein is mainly 
involved in deglutathionylation reactions. I also showed that Grx1 and Grx2 are 
fully in the dithiol state in bloodstream and procyclic cells, respectively, and 
return to their reduced states within 5 min after the removal of an oxidative 
stress. 
 
 
 
Zusammenfassung 
Glutaredoxine (Grxs) sind kleine ubiquitäre Oxidoreduktasen. Trypanosoma brucei, 
der Erreger der afrikanischen Schlafkrankheit, besitzt zwei Dithiol-Glutaredoxine. 
Vorherige Studien zeigten, dass RNA Interferenz gegen Grx2 zu einem 
Wachstumsdefekt in der prozyklischen Insektenform führt, während die 
Depletierung von Grx1 keinen phenotypischen Effekt hatte weder in Säuger-
Blutstrom noch in prozyklischen Zellen.  
Ziel meiner Doktorarbeit war die detaillierte Untersuchung der physiologischen Rolle 
von Grx1 und Grx2. Zu diesem Zweck wurden Blutstromform-Zelllinien, denen beide 
Allele von Grx1 oder Grx2 fehlten, hergestellt. Unter Standard-Kulturbedingungen 
zeigten beide mutierte Zelllinien keinen Wachstumsdefekt, auffallend war jedoch, 
dass diese im Vergleich zum Wildtyp ein verbessertes Wachstum bei erhöhter 
Temperatur aufwiesen. Die Immunfluoreszenz-Mikroskopie DAPI-gefärbter Zellen 
ließ einen signifikant höheren Anteil an Zellen mit mindestens zwei Kinetoplasten 
und zwei Zellkernen in der Wildtyp-Population im Vergleich zu den  defizienten 
Zelllinien erkennen. Die beiden Glutaredoxine können sich nicht gegenseitig 
ersetzen. In Blutstromform-Zellen kam es zu keiner Hochregulierung des einen bei 
Fehlen des anderen Proteins. Die Behandlung von rekombinantem Grx1 mit 
GSH/Diamid führte zu einer Glutathionylierung des dritten Cysteins außerhalb des 
aktiven Zentrums zusammen  mit einer dreifach verminderten Aktivität, Glutathion-
gemischte Disulfide zu reduzieren. Prozyklische Grx1-defiziente Zellen konnten 
ebenfalls hergestellt werden. Das Protein war selbst unter unterschiedlichsten 
Stressbedingungen nicht essentiell. Im Falle des Grx2 hingegen konnte das zweite 
Allel nur in Zellen ersetzt werden, die eine induzierbare ektopische Kopie von 
entweder Wildtyp oder C34S Grx2, nicht aber die C31S/C34S Mutante, besaßen. 
Beide Zelllinien exprimierten die ektopische Kopie bereits ohne Induktion, sobald das 
zweite grx2 Allel ausgeschaltet wurde. Dies deutet auf eine essentielle Rolle des 
Proteins in prozyklischen Zellen hin, da das System in Parasiten, die noch ein grx2 
Allel besaßen, streng kontrollierbar war. Diese Ergebnisse weisen darauf hin, dass 
Grx2 eine Redoxfunktion in prozyklischen Zellen besitzt, die zumindest das N-
terminale Cystein des aktiven Zentrums benötigt. In vitro Assays mit Wildtyp und 
C34S Grx2 legen nahe, dass das Protein hauptsächlich an Deglutathionylierungen 
beteiligt ist. Ebenso konnte ich zeigen, dass Grx1 und Grx2 sowohl in Blutstromform 
als auch in prozyklischen Zellen vollständig als Dithiol vorliegen und innerhalb von 5 
min nach Entfernung eines oxidative Stresses wieder in ihren reduzierten Zustand 
zurückkehren. 
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1 Introduction  
1.1 Trypanosomes and African sleeping sickness 
Human African Trypanosomiasis (sleeping sickness) is caused by Trypanosoma 
brucei species transmitted by tsetse fly of the genus Glossina (Brun et al., 
2010). The disease is fatal if left untreated and mainly affects the poor and 
rural areas of sub-Saharan Africa (Brun et al., 2010). Currently, the number of 
cases are between 50 000 – 70 000 (Brun et al., 2010). The protozoan parasites 
are kinetoplastids which live and multiply extracellularly in the blood and 
tissue fluids of mammalian hosts. Kinetoplastids are flagellated protozoans 
that contain mitochondrion DNA called kinetoplast in their single 
mitochondrion (Stuart et al., 2008). Trypanosoma brucei rhodesiense (T.b. 
rhodesiense) and Trypanosoma brucei gambienses (T.b. gambienses) are the 
only ones that infect humans (Roditi and Lehane, 2008). T.b. rhodesiense 
causes the acute form of the disease endemic in East Africa whilst T.b. 
gambienses causes the chronic form of the disease in West and Central Africa 
(Migchelsen et al., 2011). Over 95 % of cases of sleeping sickness are due to 
T.b. gambienses (Jones and Avery, 2015). There are two stages of the disease. 
In the first stage, the parasites live in the blood and lymph system and the 
symptoms include itching, headache and fever (Steverding, 2010). In the 
second stage, the parasites invade the central nervous system and symptoms 
are of neurological and endocrinical disorders (Steverding, 2010). 
Trypanosoma brucei brucei, which is a closely related parasite, infects 
livestock, but not humans and is often used in laboratory studies (Roditi and 
Lehane, 2008). Animals can be infected by other trypanosomes which are 
transmitted by tsetse flies that include T. congolenses, T. vivax and T. simiae 
(Roditi and Lehane, 2008).  
 
1.2 Life cycle of Trypanosoma brucei 
Trypanosoma brucei proliferate in mammalian hosts (bloodstream form) and in 
the midgut of the tsetse fly (procyclic form). Metacyclic trypomastigotes 
(growth-arrested form) are delivered to the mammals through the bite of an 
infected tsetse fly (Langousis and Hill, 2014). The metacyclic forms are adapted 
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to survive upon entering the mammals (MacGregor et al., 2012). When in the 
bloodstream, the metacyclic trypomastigotes differentiate into the long 
slender forms that then multiply by binary fission. At high density in 
bloodstream, the long slender forms differentiate to non-proliferative short 
stumpy forms which are ready for retransmission upon biting by the tsetse fly 
(Matthews, 2005). In the midgut of the tsetse fly, the stumpy-form of the 
parasites then differentiate to procyclic trypomastigotes which then resume 
the multiplication within the parasite (Langousis and Hill, 2014) and  long 
slender forms die (Dyer et al., 2013). Tryanosomes migrate to the 
proventriculus of the tsetse fly where they transform to long trypomastigotes  
which would then divide asymmetrically to form long and short epimastigotes 
(Dyer et al., 2013). The generalized life cycle of T. brucei is shown in Figure 1. 
 
Figure 1. Life cycle of T. brucei. Trypanosomes can multiply both in the tsetse fly and 
mammalian host. Shown are the different stages of the parasites in the tsetse fly or 
mammals. The long slender form multiplies within the mammalian host. In a density 
dependent manner, these parasites transform into short stumpy forms, ready for uptake by 
the tsetse fly. Here the short stumpy forms differentiate into proycyclic trypomastigotes 
which then multiply in the midgut of the tsetse fly. In the proventriculus, the procyclic 
trypomastigotes undergoes restructuring to form epimastigotes. The epimastigotes, when 
at salivary glands, eventually divide to form the infectious metacyclic trypomastigotes which 
are adapted to survive within the mammalian host (Langousis and Hill, 2014). 
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Trypanosomes are constantly attacked by the immune system, but they survive 
long-term due to antigenic variation of the variant surface glycoprotein (VSG) 
that involves the stochastic switching to a new VSG that has a varied coat 
(Morrison et al., 2009). There are about 107 identical VSG molecules on the 
surface of the parasites that create a coat that prevents detection of invariant 
antigens (Stockdale et al., 2008). When in the tsetse fly, the parasites 
differentiate to procyclic form by losing their VSG and replacement by 
procyclins which are glycoproteins characterized by internal Glu-Pro (EP) or 
Gly-Pro-Glu-Glu-Thr (GPEET) repeats (Roditi and Lehane, 2008). The procyclins 
protect the parasites from proteases in the midgut of the tsetse fly (Roditi and 
Lehane, 2008). 
1.3 Current drugs for African sleeping sickness 
The current drugs against the two stages of African sleeping sickness are 
summarized in Table 1. 
Table 1. Current drugs for African sleeping sickness 
 Drug Mode of action 
T.b. rhodesienses sleeping sickness  
stage 1 Suramin inhibits many enzymes through 
electrostatic  interactions (Denise and 
Barrett, 2001) 
stage 2 Melarsoprol interacts with thiols, targets might 
include trypanothione (Denise and 
Barrett, 2001) 
T.b. gambienses sleeping sickness  
stage 1 Pentamidine interacts tightly with kinetoplast though 
there might be other targets (Denise 
and Barrett, 2001) 
 
stage 2 
Melarsoprol as mentioned above 
Eflornithine inhibitor of ornithine decarboxylase 
(Delespaux and de Koning, 2007) 
Nifurtimox production of radicals after one-
electron reduction of its nitro group 
(Denise and Barrett, 2001) 
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1.4 Unique redox metabolism of trypanosomes 
Unlike other organisms, trypanosomatids lack catalase, glutathione reductase 
(GR) and thioredoxin reductase (TrxR) (Berriman et al., 2005).Glutathione 
(GSH)/GR and thioredoxin (Trx)/TrxR systems maintain the intracellular thiol 
homeostasis in most organisms, in trypanosomes this metabolism is based on 
the dithiol trypanothione and trypanothione reductase (TR) (Comini et al., 
2013). Glutathione is made up of L-glutamate, L-glycine and L- cysteine in a 
two-step process. The first step involves the ligation of L-glutamate and L-
cysteine to form ƴ-glutamylcysteine and is catalyzed by ƴ-glutamylcysteine 
synthetase. Glutathione synthetase then catalyses the reaction between ƴ-
glutamylcysteine and glycine to form glutathione (Manta et al., 2013). 
Trypanothione is synthesized by conjugation of two glutathione molecules by a 
spermidine bridge in two ATP-dependent processes catalyzed by 
trypanothione synthetase (TryS) (Leroux et al., 2013). Trypanothione is kept 
reduced by an NADPH-dependent trypanothione reductase (TR)(Comini et al., 
2013). Transfer of reducing equivalents from trypanothione can be mediated 
by thioredoxin- (Trx), tryparedoxin- (TXN) and glutaredoxin-type 
oxidoreductases (Comini et al., 2013). 
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Figure 2. (A) Redox metabolism in trypanosomatids is based on trypanothione which is 
made up of two glutathione molecules (black) joined by a spermidine bridge (red)(figure 
taken from Krauth-Siegel and Comini 2008). (B) Trypanothione reductase (TR), an NADPH-
dependent flavoenzyme, catalyses the reduction of trypanothione disulfide (TS)2 to 
trypanothione (TSH)2. Trypanothione is the direct reducing agent for the parasite 
thioredoxin (Trx), tryparedoxin (TXN) and dithiol glutaredoxin (2-C-Grx) type 
oxidoreductases, as well as for glutathione disulfide (GSSG). TXN is by far the most efficient 
multipurpose oxidoreductase of the parasites (Figure and text taken from Comini, Krauth-
Siegel and Bellands, 2013). 
A 
 B 
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1.5 Glutaredoxins 
Glutaredoxins are small ubiquitous enzymes involved in redox homeostasis. 
Glutaredoxins are found in every organism and can be localized  in different 
cellular compartments (Stroher and Millar, 2012). There are two main classes 
for glutaredoxins. Class I consists of glutaredoxins with Cys-Pro-Tyr-Cys 
sequence in the active site (Lillig et al., 2008). Class II consists of monothiol 
glutaredoxins with Cys-Gly-Phe-Ser as typical active site sequence and these 
glutaredoxins have been shown to be involved in iron-sulfur cluster assembly 
(Lillig et al., 2008). Class III are the CC-type glutaredoxins that have an active 
site with CC(M/L)(C/S) and is restricted to angiosperms (Stroher and Millar, 
2012). ROXY is widely used in Arabidopsis as the name for the glutaredoxin of 
this class III (Stroher and Millar, 2012). 
Glutaredoxins are members of the thioredoxin superfamily that share a 
common structural motif called the Trx fold. Other members of the thioredoxin 
family include protein disulfide-isomerases (PDI), thioredoxin, glutathione 
peroxidases and glutathione transferase (Stroher and Millar, 2012). The 
oxidoreductases of the Trx family share a similar active site motif Cys-X-X-Cys 
or Cys-X-X-Ser (Lillig et al., 2008). The general structure of the Trx fold is shown 
in Figure 3. 
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Figure 3. (A) Architecture of Grxs; α-helices are drawn as rectangles, β-sheets as arrows. N- 
and C- terminal conserved regions of the Trx fold are indicated in colour. (B) Structure of 
HsGrx2 (PDB code 2FLS). Same colour codes as in (A), the N- and C-terminus are indicated 
(text and figure from Stroher and Millar, 2012). 
 
Protein glutathionylation is the formation of a mixed disulfide between a 
protein cysteine and glutathione (Klatt and Lamas, 2000). This modification can 
have a regulatory role in a cell as well means to store glutathione and to 
protect proteins under oxidative stress by preventing irreversible oxidation of 
thiols (Dalle-Donne et al., 2008). Protein deglutathionylation is frequently 
catalyzed by glutaredoxins (Dalle-Donne et al., 2008). Dithiol glutaredoxins can 
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catalyze reactions that proceed via two distinct mechanisms - the dithiol and 
monothiol mechanisms (Lillig et al., 2008). Reduction of protein-mixed 
disulfides proceed via a monothiol mechanism which requires only the N-
terminal active site cysteine to reduce the mixed disulfide between the protein 
and glutathione (Stroher and Millar, 2012). The reduction of protein disulfides 
goes via a dithiol mechanism whereby the two active site cysteines are 
involved (Lillig et al., 2008). In this reaction, the N-terminal cysteine performs a 
nucleophilic attack on the target disulfide resulting in a mixed disulfide 
between the cysteine and target. In the next step, the second active site 
cysteine attacks the mixed disulfide intermediate (Lillig et al., 2008). The 
intramolecular disulfide formed between the two active site cysteines is then 
reduced by two glutathione molecules (Stroher and Millar, 2012). The two 
mechanisms are depicted in Figure 4. 
 
 
Figure 4. Reaction mechanisms of glutaredoxins. Glutaredoxins catalyze the reversible 
reduction of protein disulfides utilizing both their active site cysteinyl residues (reactions 1-
4). Disulfides between glutathione and proteins or low molecular weight compounds are 
reduced in the monothiol mechanism that requires only the more N-terminal active site 
cysteinyl residue (reactions 6 and 4). In either case, glutathione disulfide formed in the 
reaction is reduced by glutathione reductase at the expense of NADPH (reaction 5)(figure 
and text taken from Lillig, Berndt and Holmgren 2008). 
1.6 Glutaredoxins in Trypanosoma brucei  
T. brucei contains three monothiol glutaredoxins (1-C-Grx1 to 3) and two 
dithiol glutaredoxins (Grx1 and Grx2) (Comini et al., 2013). The two dithiol 
proteins were partially characterized by Ceylan et al. 2010. Grx1 and Grx2 are 
located in the cytosol and probably in the intermembrane space of the 
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mitochondrion, respectively. Both proteins are kept reduced by direct reaction 
with trypanothione. Recombinant T. brucei Grx1, but not Grx2, was shown to 
coordinate iron-sulfur clusters. Grx1 was shown to catalyze the reduction GSH-
protein mixed disulfides with 10-fold activity than of Grx2. In addition, Grx1 
strongly accelerated the reduction of glutathione disulfide by trypanothione. 
RNA interference against Grx1 showed no growth phenotype in both 
bloodstream and procyclic form of T. brucei, but RNAi against Grx2 in procyclic 
cells resulted in a proliferation defect (Ceylan et al., 2010). Recombinant Grx1 
could supply electrons for the reduction of ribonucleotide reductase by 20 to 
50 % activity of that tryparedoxin (Tpx). Grx2 has a CQFC active site and was 
shown to catalyze the reduction of protein disulfides and glutathione-protein 
mixed disulfides although the latter reaction is less efficient when compared to 
Grx1 (Ceylan et al., 2010). 
1.7 Aim of the PhD thesis 
This work comprised 
(i) To generate bloodstream and procyclic cell lines that lack Grx1, Grx2 or both 
Grx1 and Grx2 (if possible) 
(ii) To characterize the mutant cell lines under various forms of stress 
(iii) To determine the in vivo redox state of the Grxs under normal and 
oxidizing conditions 
(iv) In vitro glutathionylation of Grx1 and determination of its effect on activity 
(v) To generate conditional knockouts with either wildtype or mutant ectopic 
copies of Grx2 in procyclic cells 
(v) To study bloodstream knockout cell lines compared to wildtype cells at an 
elevated temperature 
(vi) To determine the role of the dithiol Grxs in the intact parasites 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Chemicals 
Acetone Applichem, Darmstadt 
Agar Life Technologies,Darmstadt 
Agarose (standard) low 
electroendosmosis 
Biomol, Hamburg 
AMS Life Technologies, Darmstadt 
Bathocuproinedisulfonic acid 
disodium salt                          
Sigma Aldrich, Steinheim 
Blasticidin S hydrochloride   Carl Roth, Karlsruhe 
Carbenicillin  Serva, Heidelberg 
DAPI Sigma Aldrich, Steinheim 
Deferoxamine mesylate Sigma Aldrich, Steinheim 
DTT Biomol, Hamburg 
EDTA  Applichem, Darmstadt 
Ethanol  Sigma Aldrich, Steinheim 
Fetal calf serum Biochrom, Berlin 
G418 Sulfate, cell culture tested Merck Millipore, Darmstadt 
Hemin Sigma Aldrich, Steinheim 
Hydrogen peroxide Merck Millipore, Darmstadt 
Hygromycin B Carl Roth, Karlsruhe 
Hypoxanthine Sigma Aldrich, Steinheim 
Iron(II) sulfate heptahydrate                           Sigma Aldrich, Steinheim 
Iron(III) nitrate nonahydrate Sigma Aldrich, Steinheim 
Iscove’s modified Dulbecco’s medium           Life Technologies, Darmstadt 
Kanamycin Serva, Heidelberg 
L-Cysteine, non-animal source Sigma Aldrich, Steinheim 
MEM non-essential amino acids Sigma Aldrich, Steinheim 
MEM vitamins Sigma Aldrich, Steinheim 
Mem-Pros (with L-Glutamine, without 
NaHCO3)        
Merck Millipore, Darmstadt 
Milk powder Carl Roth, Karlsruhe 
NaOH  Merck Millipore, Darmstadt 
NEM  Sigma Aldrich, Steinheim 
Penicillin/Streptomycin Sigma Aldrich, Steinheim 
Phenol red  Merck Millipore, Darmstadt 
Phleomycin Sigma Aldrich, Steinheim 
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Puromycin dihydrochloride      Sigma Aldrich, Steinheim 
SDS    Serva, Heidelberg 
Sodium chloride Sigma Aldrich, Steinheim 
Tetracyclin-hydrochloride Sigma Aldrich, Steinheim 
Trypton/Pepton from Casein Carl Roth, Karlsruhe 
Tween 20  Merck Millipore, Darmstadt 
Yeast Extract Carl Roth, Karlsruhe 
β-Mercaptoethanol Sigma Aldrich, Steinheim 
 
2.1.2 Consumables 
24-well cell culture plate (662160) Greiner Bio-One, Frickenhausen 
Amicon Ultra-15 concentrator Merck Millipore, Darmstadt 
BL21 (DE3) cells Merck Millipore, Darmstadt 
Cell culture flasks (250 ml, 550 ml)                  Greiner Bio-One, Frickenhausen 
Digital thermometer  (GT11700)                      GHM Messtechnik, Regenstauf 
DNA Taq polymerase   Thermo Fisher Scientific, 
Lithuania 
DNeasy Blood and Tissue Kit (Cat. No. 
69504)    
Qiagen, Hilden 
Filter Tips Universal (10, 100, 1000 µL Greiner Bio-One, Frickenhausen 
Gene Rulers (100 bp and 1 kb)                          Thermo Fisher Scientific, 
Lithuania 
Goat anti-guinea pig IgG-HRP Santa Cruz Biotechnology, USA 
Goat anti-mouse IgG-HRP Santa Cruz Biotechnology, USA 
Goat anti-rabbit IgG-HRP  Thermo Fisher Scientific, USA 
Guinea pig anti-Grx1 Eurogentec, Belgium 
Guinea pig anti-Grx2 Eurogentec, Belgium 
Mouse anti-myc Roche, Mannheim 
Novablue cells Merck Millipore, Darmstadt  
Nucleobond Xtra Midi Macherey-Nagel, Düren 
Pfu DNA Polymerase Thermo Fisher Scientific, 
Lithuania 
Stericup-GP Filter unit 0.22 µm, 500 ml             Merck Millipore, Darmstadt 
Super Signal West Pico Kit Thermo Fisher Scientific, USA 
Tissue culture flasks (50 ml) Becton Dickinson, Heidelberg 
Whatman paper 3 MM     Whatman, Dassel 
Zymoclean Gel DNA Recovery (D4002) Hiss Diagnostic, Freiburg 
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2.1.3 Primers 
All primers were synthesized by Eurofins MWG Operons, Ebersberg, Germany 
and are listed in Tables 2A and B. 
 
Table 2A. List of Grx1 primers  
Purpose  Name Sequence (restriction sites 
in bold) 
Amplification of grx1  
5‘ UTR for ligation 
into 
pHD1747/pHD1748 
for the generation of  
knock-out cell lines 
5UTR-5aF-grx1 -XhoI  
 
AGATCTCGAGGTAACTGCA
TCACGCAC    
5UTR-5bR-grx1-HindIII 
 
TTAAAGCTTGATACCACGTG
TTGGGGAC 
 
Amplification of grx1  
3‘ UTR for ligation 
into 
pHD1747/pHD1748 
for the generation of 
knock-out cell lines 
3UTR-3aF-grx1-EcoRI AGAGAATTC 
TAGTGCCAAACGAGAGGTG 
 
3UTR-3bR-grx1-NotI GTGCGGCCGCGTGCTAAAA
GGCGATCTTC 
 
To confirm insertion 
of the resistance 
cassette into the Grx1 
locus 
Grx1-5utrFW_BM  
 
GTCTATGCTGCGCAATAGG
GAT 
PuroR_BM2 CACACCTTGCCGATGTCGAG 
BlaRev   GAGCTGCGCTGGCGACG 
To verify the deletion 
of grx1 alleles  
Grx1 1Fo (P337) CATG CCC TCT ATC GCT  
TCG 
Grx1 1Re (P334) CGT TTC GTG TTT GTA TGC 
TTG                  
To verify presence of 
peroxidase II 
Px IIF (Michi's P26) 
 
ATGTCAGCTGCTTCGTCAAT
C 
Px IIR (Michi’s P18) 
 
AGACGCGCTCTGCGTGCT 
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Table 2B. List of Grx2 Primers 
Purpose Name Sequence (restriction 
sites in bold) 
Amplification of grx2  5‘ UTR 
for ligation into 
pHD1747/pHD1748 (neo) for 
the generation of  knock-out 
cell lines 
Tb2CGrx2_5’_1f 
 
CTGCTCGAGCTCTTTTAC
TAAGGTAG 
Tb2CGrx2_5’_2r CTCAAGCTTCCTCACAGC
AACGTAC 
Amplification of grx2  3‘ UTR 
for ligation into 
pHD1747/pHD1748(neo) for 
the generation of knock-out 
cell lines 
Tb2CGrx2_3’_7f CGAGAATTCGGGGCTGA
AGAGG 
Tb2CGrx2_3’_4r AATGCGGCCGCCGAGCA
GCATACAAC 
 
To confirm insertion of the 
resistance cassettes into the 
grx2 locus 
5UTRGrx2F_BM CTTCACTCTCAAACTTATG
TAGG 
PuroR_BM2 CACACCTTGCCGATGTCG
AG 
NeoR_BM CATCAGCCATGATGGATA
CTTTC 
 
To verify the deletion of 
grx2 alleles  
2CGrx2F_BM ggatgaataacgcattggatc 
2CGrx2R_BM 
 
cttctgcaaacacttcacgac 
5UTRGrx2-2F_BM GTACGTTGTTGTGAGGG
ACCTA 
3UTRGrx2_2R_BM CCTATGCTCACAATACAT
AAAC 
 
To mutate Cys34  into a 
serine 
2CGrx2_C34S_f 5’ GCCACGTATTGTCAGTTC
TCCACAAAACTGAAGATG
TTAC 
2CGrx2_C34S_r 5’ GTAACATCTTCAGTTTTG
TGGAGAACTGACAATAC
GTGGC 
 
To mutate both Cys31 and 
Cys34 to serine 
2CGrx2_Dmut_f 5’ GTCCGCCACGTATTCTCA
GTTCTCCACAAAACTGAA
GATG 
2CGrx2_Dmut_r 5’ CATCTTCAGTTTTGTGGA
GAACTGAGAATACGTGG
CGGAC 
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To introduce a stop codon in 
the pHD1700-Grx2-c-myc2 
construct 
 
2CGrx2_Stop_F 5’ 
 
GAAATTGAAAGGGGCTG
AGGATCCAACGAGCAAA
AG 
2CGrx2_Stop_r 5’ 
 
CTTTTGCTCGTTGGATCCT
CAGCCCCTTTCAATTTC 
 
2.1.4 Vectors 
The vectors (pHD1747, pHD1748 and pHD2171) were kindly provided by Dr. 
Christine Clayton (ZMBH, Heidelberg). 
 
2.1.5 Antibodies 
The antibodies used in this work are listed in Table 3. 
Table 3. List of primary and secondary antibodies 
Primary antibody Secondary antibody 
 Dilution  Dilution 
α-Grx1 1:800 α-guinea pig 1:10000 
α-Grx2 1:200 α-guinea pig 1:10000 
α-Grx2 1:200 α-rabbit 1:20000 
α-TXNPx 1:6000 α-rabbit 1:20000 
α-Myc 1:800 α-mouse 1:20000 
 
2.1.6 Media for E. coli cultivation 
 
LB Medium   (1 l) 
Yeast extract              5 g 
Sodium chloride                            5 g 
Trypton/Pepton             10 g 
Water (sterile)      ad                    1 l 
pH 7.5 (NaOH) 
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2 YT Medium (1 l) 
Yeast extract   10 g 
Sodium chloride                  10 g 
Trypton/Pepton   20 g 
Water (sterile)    ad  1 l     
pH 7.5 (NaOH) 
 
 
2.1.7 Media for T. brucei cultivation 
 
HMI-9 Medium for bloodstream cells (10 l) 
Iscove’s modified Dulbecco’s Medium        176.6  g  
NaHCO3          30.24 g 
Hypoxanthine         1.36 g 
Sodium pyruvate                              1.1 g 
Thymidine          0.39 g 
Bathocuproine disulfonic acid disodium                       0.28 g 
Water (sterile)   ad         10 l 
pH 7-7.5 (NaOH)  (adjusted if necessary) 
 
Complete HMI-9-Medium ( 1 l) 
HMI-9-Medium                        900 ml 
Fetal calf serum (inactivated at 60 oC, 1h)                            100 ml 
Pen/Strep (5000 U/ml; 5 mg/ml)                                            10 ml 
β-Mercaptoethanol (14 M)               14 µl 
L-Cysteine (150 mM in sterile water)             10 ml  
Phleomycin  (2.5 mg/ml in sterile water)                        80 µl 
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Complete MEM-Pros-Medium for procyclic cells (1 l) 
*1 x Basic-MEM (pH 7.4 (NaOH))                  900 ml 
FCS (inactivated)                 100 ml  
Pen/Strep (5000 U/ml; 5 mg/ml)               10 ml 
Hemin (2.5 mg/ml in 0.1 M NaOH)                         2.8 ml   
100 x MEM-vitamins                 10 ml 
100 x MEM non-essential amino acids               10 ml 
10 mg Phenol red                  10 mg 
Phleomycin (2.5 mg/ml in sterile water)             200 µl 
 
*1 x Basic MEM with L-glutamine and without NaHCO3 dissolved in water and 
pH adjusted to pH 7.4 with NaOH. Powder for 5 l dissolved in 4.5 l. Aliquoted 
into 450 ml or 900 ml. 
 
2.1.8 Parasites 
The parasites used in this work were of the T. brucei brucei  449 strain which is 
a descendant of Lister 427 (Cunningham and Vickerman, 1962). 
 
2.1.9 Antibiotics for T. brucei cell culture medium 
Both bloodstream and procyclic cells were cultured in medium that contained 
50 U/ml penicillin and 0.05 mg/ml streptomycin. Additionally, complete HMI-9 
and complete MEM-Pros medium contained 0.2 and 0.5 µg/ml phleomycin, 
respectively. For selecting the clones after transfection (see below), the 
antibiotics listed in Table 4 were used. 
 
Table 4. Antibiotics used for selection purposes 
 Concentration for 
bloodstream cells 
(µg/ml) 
Concentration for 
procyclic cells 
(µg/ml) 
Hygromycin 10 50 
Tetracycline 1 1 
Puromycin 0.2 2 
Blasticidin 5 10 
Neomycin/G418 2.5 30 
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2.2 Methods 
 
2.2.1 Sequencing 
All plasmids were sequenced by EuroFins MWG Operons, Ebersberg, Germany 
or GATC Biotech AG, Konstanz, Germany. 
 
2.2.2 Cultivation of T. brucei 
Wildtype bloodstream form parasites were cultivated in HMI-9 medium at 37 
oC in a humidified incubator with 5 % CO2. Procyclic cells were grown at 27 
oC 
in MEM-Pros medium. Both media were supplemented with 10 % (v/v) heat-
inactivated fetal calf serum. After grx1 or grx2 alleles had been knocked out (in 
the absence of an ectopic copy), the resulting double knockout (KO) clones 
were grown in the absence of the selecting antibiotics. 
 
2.2.3 Glycerol stocks 
Procyclic cells were harvested by centrifugation at 2000 rcf and 4 oC for 10 min 
and resuspended in 10 % sterile glycerol (in complete MEM-Pros medium) to a 
final density of 1 x 107 cells/ml. Bloodstream form cells were harvested by 
centrifugation at 2000 rcf and 4 oC for 10 min and resuspended in 10 % sterile 
glycerol (in complete HMI-9 medium) to a final density of 6 x 106 cells /ml. The 
cells were stored as 1 ml aliquots in cryo tubes at -80 oC. 
 
2.2.4 Isolation of genomic DNA from T. brucei  
Genomic DNA was isolated from 5 x 106 bloodstream form parasites using the 
Qiagen DNeasy Blood and Tissue kit. 
 
2.2.5 Isolation of plasmids from E. coli 
Plasmid DNA amplified in E. coli was isolated using the NucleoBond Extra Midi 
kit. 
 
2.2.6 PCR analyses 
PCR analyses were performed with the Eppendorf Master Cycler and Taq DNA 
polymerase (for analytical purposes) or Pfu polymerase (for cloning purposes).  
The general program for PCR is given in Table 5. 
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Table 5. General PCR program 
Step Temperature (oC) Time 
1. Denaturation 95 3 min 
2. Addition of 
polymerase 
80 (pause)  
3. Denaturation 95 30 s 
4. Annealing variable 30 s 
5. Extension 72  1 min/kb 
6. *Repeat    
7. Final elongation  72 10 min 
*Steps 3 to 5 were repeated for 30 cycles. 
 
2.2.7 Mutagenesis of plasmids for parasite transfection and 
expression of recombinant proteins 
 
2.2.7.1 Mutagenesis of pHD1700/grx2-c-myc2 vector to express ectopic tag-
free Grx2 
In order to express a tag-free ectopic of Grx2 protein in the parasites under tet 
control, the vector pHD1700/grx2-c-myc2 (Ceylan et al., 2010) was used as 
template and a stop codon was introduced after the grx2 sequence using 
QuickChange Multi Site-Directed Mutagenesis Kit and the primers 
2CGrx2_Stop_F 5’ /2CGrx2_Stop_r 5’ (see Table 2B) to generate vector 
pHD1700/grx2. 
 
2.2.7.2 Mutagenesis of either one or both active site cysteines to serine in 
the pHD1700/grx2 vector  
Vector pHD1700/grx2 generated as described above was used as a template 
and either cysteine 34 or both cysteines 31 and 34 were replaced by serine 
using the QuickChange Multi Site-Directed Mutagenesis Kit to generate 
pHD1700/grx2c34s or pHD1700/grx2c31sc34s, respectively. 
  
2.2.7.3 Plasmids for expression of wildtype and cysteine mutants of 
recombinant Grx2 
To generate cysteine mutants of recombinant Grx2 (C34S or C31S/C34S), 
plasmid pETtrx1b/grx2 (Ceylan et al., 2010) was subjected to site-directed 
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mutagenesis of either one or both cysteines to serine using the QuickChange 
Multi Site-Directed Mutagenesis Kit. The pETtrx1b/grx2c34s and 
pETtrx1b/grx2c31sc34s constructs obtained were then used to express and 
purify the recombinant proteins according to published procedure (Ceylan et 
al., 2010). The concentration of the proteins was determined by the Bradford 
method. 
 
2.2.8 Agarose gel electrophoresis 
Agarose gels were prepared by dissolving 1 - 2 % agarose in 1 x TAE buffer. The 
DNA samples were mixed with 10 x sample buffer and loaded onto the gel. 
DNA fragments were separated by electrophoresis at a constant voltage of 100 
V in 1 x TAE buffer at room temperature. The gel was put in approximately 
0.04 % ethidium bromide solution for about 10 min before the DNA bands 
were visualized under UV light. 
 
50 x TAE buffer (500 ml) 
 MW (g/mol) Amount 
2 M Tris  121.14 121.14 g 
0.1 M EDTA 372.24 18.61 g 
pH 8.3 (conc. Acetic 
acid) 
28.57 ml  
  
1 x TAE (2 l) 
50 x TAE      40 ml   
Water (bidest.) ad     2 l  
 
2.2.9 Western blot analyses 
A polyvinylidene fluoride (PVDF) membrane was soaked in methanol and 
arranged in a ‘sandwich’ composed of a sponge, 4 Whatman papers, the SDS 
gel, the PVDF membrane, 4 Whatman papers and a sponge. The ‘sandwich’ 
was put into a Western blotting chamber that contained 1 x Western blotting 
buffer. The transfer was carried out for 2 h at a current of 150 mA at room 
temperature. After transfer, the membrane was treated for 1 h with 20 ml of 5 
% milk powder in TBS-T buffer, washed 3 x with TBS-T buffer for 5 min and 
incubated overnight with the primary antibodies, diluted in 5 % milk powder in 
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TBS-T buffer. Subsequently, the membrane was washed three times with TBS-T 
buffer for 10 min and then incubated for 1 h with the secondary antibodies 
diluted in 5 % milk powder in TBS-T buffer. The membrane was washed again 3 
x with TBS-T buffer and then developed with SuperSignal West Pico 
chemiluminescent substrate in the darkroom. 
 
10 x Western blotting buffer (1 l) 
 MW  
(g/mol) 
Amount (g) 
248 mM Tris 121,14 30 
1.86 M Glycine 75,07 140 
 
1 x Western blotting buffer (1 l) 
10 x Western blotting buffer   100 ml 
Methanol                   200 ml 
Water (bidest.)              700 ml 
 
10 x TBS buffer (1 l)  
 MW 
(g/mol) 
Amount  
1 M Tris  121,14 121 g 
1.5 M Sodium chloride 58,44 90 g 
pH 7.5 (conc. HCl)  63 ml 
 
1 x TBS-T buffer (1 l) 
10 x TBS       100 ml 
Tween 20        500 µl 
Water (bidest.) ad      1 l  
 
Western blot stripping 
To remove bound antibodies, the membrane was incubated with 50 ml of 
stripping buffer for 1 h at 50 oC in a water bath. The membrane was then 
washed 3 x with TBS-T buffer for 10 min each and incubated with new 
antibodies as described above. 
 
 
21 
 
Stock solutions 
 MW 
(g/mol) 
Concentration 
   
Volume 
(ml) 
Mass 
(g) 
525 mM Tris (10 x) 121.14 500 mM 50 3.03 
pH 6,8 (conc. HCl) 
 
10 % SDS (5 x)  100 g/l 50 5 
  
Stripping Buffer (50 ml) 
 Volume (ml) Final concentration 
525 mM Tris 5 52.5 mM 
10 % SDS 10 2 % 
14 M β-mercaptoethanol 0.35 98 mM 
Water (bidest.) 35  
 
2.2.10 Silver staining 
The gels were stained at room temperature according to the Fast Silver 
Staining Protocol of the Price Lab 
(http://www.labspaces.net/protocols/15291206472756_protocol.pdf).  
The solutions required are listed in Table 6. They were freshly prepared. 100 
ml of each solution was used per gel (plus 12.5 ml citric acid). The gel was 
soaked for 10 min in fixing solution, washed twice with water for 5 min, soaked 
for 1 min in 0.02 % sodium thiosulfate solution and washed again twice in 
water for 20 s. The gel was then treated for 10 min with 0.1 % silver nitrate, 
rinsed with water, followed by a small amount of developing solution and 
finally soaked in fresh developing solution (formalin was added freshly) until 
protein bands were visible (approx. 1 - 3 min). 12.5 ml of 2.3 M citric acid was 
added to stop the reaction and the tray was shaken for 10 min. The gel was 
washed for 10 min in water and then soaked for at least 30 min in water 
before drying.  
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Table 6. Solutions for silver staining 
 Final solution Composition 
Fixing solution 40 % (v/v) ethanol 
13.5 % (v/v) formalin 
40 ml  absolute ethanol 
13.5 ml formalin 
water ad 100 ml (bidest.)   
Sodium 
thiosulfate 
0.02 % (w/v) Na2S2O3 0.02 g of Na2S2O3 
dissolved in 100 ml water 
(bidest.) 
Silver nitrate 0.1 %  (w/v) AgNO3 0.1 g of AgNO3 dissolved 
in 100 ml water (bidest.) 
Developing 
solution 
3 % (w/v) sodium 
carbonate 
0.000016 % (w/v) Na2S2O3 
0.05 % (w/v) formalin 
 
3 g of sodium carbonate 
dissolved in 100 ml water 
(bidest.). 
add 80 µl of a 0.02 % 
Na2S2O3 
Before use: add 50 µl of 
formalin 
Citric acid 2.3 M citric acid 6 g of citric acid dissolved 
in 12.5 ml water (bidest.) 
*Note: Formalin is a commercial solution of 37 % formaldehyde. 
 
2.2.11 Generation of Grx1 knockout cell lines in bloodstream and 
procyclic cells 
 
2.2.11.1 Cloning of the constructs for deletion of the grx1 alleles in T. brucei 
Genomic DNA was isolated from bloodstream form T. brucei as described in 
section 2.2.4. The 5’- untranslated region of grx1 was amplified from the 
genomic DNA by PCR with Pfu polymerase and 5UTR-5aF-grx1-XhoI and 5UTR-
5bR-grx1-HindIII as primers, generating a fragment of 401 bp. The 3’ 
untranslated region was amplified using the primers 3UTR-3aF-grx1-EcoRI and 
3 UTR-3bR-grx1-NotI, yielding a fragment of 380 bp. Each fragment was 
purified from a 2 % agarose gel using the Zymoclean Gel DNA Recovery kit and 
ligated into the pGEM-T vector according to the manufacturer’s protocol 
(pGEM-T and pGEM-T Easy Vector Systems) and amplified in NovaBlue cells. 
The 5’ and 3’ untranslated regions were released from the plasmid by 
digestion, and stepwise cloned into the pHD1747 (confers resistance to 
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puromycin) and pHD1748 (confers resistance to blasticidin) vectors to 
generate pHD1747-grx1-KO and pHD1748-grx1-KO, respectively (Figure 5). 
 
Figure 5. Scheme for the replacement of the grx1 alleles by resistance genes. The 5’-and 
3’-untranslated regions with XhoI/HindIII and EcoRI/NotI restriction sites, respectively, were 
cloned into the pHD1747 and pHD1748 vectors. The expected sizes of pHD1747-grx1-KO 
and pHD1748-grx1-KO cassettes after digestion with XhoI and NotI were 1375 bp and 1171 
bp (calculated using Serial Cloner program), respectively. The puromycin and blasticidin 
resistance genes have sizes of 600 bp and 399 bp, respectively.  
 
2.2.11.2 Preparation of DNA for parasite transfections 
12 µg of pHD1747-grx1-KO and pHD1748-grx1-KO, respectively, were digested 
with XhoI and NotI. The digest (50 µl) was diluted to 100 µl with sterile water. 
100 µl of 4 M ammonium acetate and 500 µl of absolute ethanol (kept at room 
temperature) were added. The sample was vortexed and incubated on ice for 
at least 15 min and then centrifuged at 13 000 rpm at 4 oC for 10 min. The 
supernatant was discarded and the pellet resuspended in 100 µl of 70 % v/v 
ethanol (at room temperature) and then centrifuged as before. The 
supernatant was carefully removed by pipetting and the pellet was allowed to 
dry under a sterile hood. 
 
2.2.11.3 Transfection of procyclic T. brucei and cloning of grx1-deficient cell 
lines 
4 x 107 wildtype procyclic cells harvested in the logarithmic growth phase were 
centrifuged at 2000 rcf for 10 min at 4 oC. The ethanol-precipitated DNA was 
mixed with 100 µl human T cell nucleofactor solution and added to the cell 
pellet. Transfection was performed in the Amaxa nucleofactor electroporator 
with the program X-001. Transfected parasites were transferred into 20 ml of 
conditional MEM-Pros medium (pre-incubated overnight at 37 oC). After 
overnight cultivation at 27 oC without any antibiotics, the parasites were 
seeded in 24-well plates by serial dilutions. Stably-transfected clones were 
selected by the respective antibiotic (2 µg/ml puromycin or 10 µg/ml 
blasticidin. Clones are obtained after about 7 days. Verified single knockout 
cells were transfected with the respective other deletion cassette (as depicted 
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in Figure 6) and clones were selected using both antibiotics. Deletion of both 
grx1 alleles was verified by both PCR and Western blot analyses. 
 
 
Figure 6. Scheme for the deletion of both grx1 alleles in procyclic T. brucei. Two deletion 
cassettes conferring resistance to blasticidin (bla, blasticidin S-deaminase gene) and 
puromycin (pac, puromycin N-acetyltransferase gene) were cloned and used for 
transfection of the parasites. Various primer combinations (indicated by arrows and 
expected amplicon sizes below) verified the replacement of both grx1 alleles by PCR 
analysis.  
 
2.2.11.4 Transfection of bloodstream T. brucei and cloning of grx1-deficient 
cell lines  
4 x 107 wildtype bloodstream cells were harvested and transfected with 12 µg 
of digested pHD1747-grx1-KO or pHD1748-grx1-KO as described before for 
procyclic cells. Transfected parasites were grown in 50 ml of HMI-9 medium at 
37 oC in a  5 % CO2 humidified incubator without any selecting antibiotic 
overnight and then seeded in 24-well plates by serial dilutions. Stably-
transfected clones were selected using the appropriate antibiotics (0.2 µg/ml 
puromycin or 5 µg/ml blasticidin).  
 
 
 
25 
 
2.2.11.5 Generation of bloodstream Grx1 KO cells that express an ectopic 
copy of Grx1-c-myc2 
Grx1 KO harboring an ectopic copy of Grx1-c-myc2 were generated by 
transfecting 4 x 107 Grx1 KO bloodstream cells with 12 µg of digested 
pHD1700/grx1-c-myc2 (Ceylan et al., 2010) using the procedure described in 
section 2.2.11.3. Transfected parasites were grown in 50 ml of HMI-9 medium 
at 37 oC in a 5 % CO2 humidified incubator without any selecting antibiotic 
overnight and then seeded in 24-well plates by serial dilutions. Stably-
transfected clones were selected using 10 µg/ml of Hygromycin. Expression of 
ectopic Grx1-c-myc2 was achieved by growing the cells overnight in medium 
containing 100 ng/ml tet. 
 
2.2.12 Generation of Grx2 knockout cell lines in bloodstream and 
procyclic cells 
 
2.2.12.1 Cloning of the constructs for deletion of the grx2 alleles in T. brucei 
Genomic DNA was isolated from bloodstream form T. brucei as described in 
section 2.2.4. The 5’ untranslated region of grx2 was amplified from the 
genomic DNA by PCR with Pfu polymerase and Tb2CGrx2_5’_1f and 
Tb2CGrx2_5’_2r as primers, generating a fragment of 388 bp. The 3’ 
untranslated region was amplified using the primers Tb2CGrx2_3’_7f and 
Tb2CGrx2_3’_4r, yielding a fragment of 416 bp. Each fragment was purified 
from a 2 % agarose gel using the Zymoclean Gel DNA Recovery kit. The 5’ and 
3’ utr of grx1 in pHD1747-grx1-KO were stepwise released by digestion with 
XhoI /Hind III and EcoRI/NotI, respectively, and replaced with the grx2 utr 
fragments to generate the pHD1747-grx2-KO deletion cassette. The blasticidin 
resistance gene in the pHD1748-grx1-KO deletion cassette was removed by 
digestion with HindIII and EcoRI and replaced with the neomycin resistance 
gene which was obtained from the pHD2171 vector by digestion also with 
HindIII and EcoRI. Subsequently, the 5’ and 3’ utr of grx1 were stepwise 
replaced by grx2 utr fragments, generating pHD1748 (neo)-grx2-KO deletion 
cassettes. 
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2.2.12.2 Transfection of bloodstream T. brucei and cloning of grx2-deficient 
cell lines 
12 µg of pHD1747-grx2-KO and pHD1748 (neo)-grx2-KO, respectively, were 
digested with XhoI and NotI. The DNA precipitation and drying procedure was 
described in section 2.2.11.2. Bloodstream parasites were harvested and 
transfected with the constructs as described in section 2.2.11.4. Stably-
transfected clones were selected using the appropriate antibiotics (0.2 µg/ml 
puromycin or 2.5 µg/ml neomycin). Verified single knockout cells were 
transfected with the respective other deletion cassette (as depicted in Figure 
7) and clones were selected using both antibiotics. Deletion of both grx2 alleles 
was verified by both PCR and Western blot analyses. 
 
 
Figure 7. Scheme for the deletion of both grx2 alleles in bloodstream and  procyclic T. 
brucei. Two deletion cassettes conferring resistance to neomycin (Neo gene) and puromycin 
(pac, puromycin N-acetyltransferase gene) were cloned and used for transfection of the 
parasites. Various primer combinations (indicated by arrows and expected amplicon sizes 
below) verified the replacement of both grx2 alleles by PCR analysis.  
 
2.2.12.3 Generation of bloodstream Grx2 KO cells that express an inducible 
ectopic copy of Grx2 
4 x 107 Grx2 KO bloodstream cells (see section 2.2.12 .2) were transfected with 
12 µg of Not I-linearised pHD1700/grx2 as described before. Transfected 
parasites were grown overnight in 50 ml of HMI-9 medium at 37 oC in a 5 % 
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CO2 humidified incubator without any selecting antibiotic and then seeded in 
24-well plates by serial dilutions. Stably-transfected clones were selected using 
10 µg/ml of hygromycin. 
 
2.2.12.4 Transfection of procyclic T. brucei and cloning of grx2-deficient cell 
lines  
4 x 107 wildtype procyclic cells were harvested and transfected with 12 µg of 
NotI -digested pHD1747-grx2-KO or pHD1748 (neo)-grx2-KO as in section 
2.2.11.3. Stably-transfected clones were selected by the respective antibiotic 
(2 µg/ml puromycin or 30 µg/ml neomycin). After grx2 single knockouts (SKO) 
were verified by PCR, deletion of the second allele was attempted using the 
other deletion cassette as depicted in Figure 7. 
 
2.2.12.5 Transfection of procyclic T. brucei Grx2 SKO cells with vectors to 
express tet-inducible ectopic copy of wildtype or mutant Grx2  
4 x 107 procyclic grx2 SKO (puro) clones were harvested as described before 
and transfected with 12 µg of Not I-linearised pHD1700/grx2, 
pHD1700/grx2c34s or pHD1700/grx2c31sc34s. Stably-transfected clones were 
selected by both 2 µg/ml puromycin and 50 µg/ml hygromycin.  
 
2.2.12.6 Generation of conditional knockout procyclic cells that express an 
ectopic copy of Grx2, Grx2C34S or Grx2C31S/C34S 
The procyclic grx2 SKO (puro) clones harboring the tet-inducible Grx2 ectopic 
copies (pHD1700/grx2, pHD1700/grx2c34s or pHD1700/grx2c31sc34s) were 
grown overnight in MEM-Pros medium containing 50 µg/ml hygromycin, 100 
ng/ml tet and 2 µg/ml puromycin and then transfected with the pHD1748-
grx2-KO deletion construct as previously described. The cells were cultured 
overnight at 27 oC in the presence of hygromycin and tet (without puromycin 
or neomycin). Stably-transfected clones were selected in medium containing 
hygromycin, tetracycline, puromycin and neomycin.  
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2.2.13 Phenotypic analyses of Grx1 KO cell lines 
 
2.2.13.1 Phenotypic analyses of Grx1 KO procyclic cell lines 
5 ml cultures of WT and Grx1 KO (Grx1-deficient) procyclic T. brucei with an 
initial density of  5 x 105 cells/ml were grown in MEM-Pros medium at 27 oC in 
the presence of diamide (0 and 20 µM) for 24 h, hydrogen peroxide (0, 2.5, 5 
and 10 µM) for 48 h, Fe (II) (Iron (II) sulfate heptahydrate) or Fe (III) (Iron (III) 
nitrate nonahydrate)  (0 µM, 100 µM and 1 mM) for 48 h and the iron (III) 
chelator deferoxamine (0, 25, 100 and 500 µM) for 48 h. The stressors were 
added only once at the beginning of the experiment and viable cells were 
counted at different time points in a Neubauer chamber. For heat shock stress, 
a 5 ml culture with 5 x 105 cells/ml in medium at 27 oC in cell culture flask was 
incubated until the temperature reached 41 oC (approximately 45 min) in an 
incubator. Time point zero was defined when the temperature had reached 41 
oC in the reference flask containing only medium, monitored with a digital 
thermometer. The temperature was maintained at 41 oC for 60 min and then 
viable cells were counted in a Neubauer chamber before the cultures were put 
back to 27 oC in the incubator for recovery. Cells were counted at various time 
points and time point  zero for the recovery was taken as the time the cultures 
were put back into the 27 oC incubator. 
 
2.2.13.2 Phenotypic analyses of Grx1 KO bloodstream form T. brucei  
5 ml of WT and Grx1 KO bloodstream cells with an initial density of 5 x 105 
cells/ml were cultured in HMI-9 medium at 37 oC in the presence of 
deferoxamine (0, 6.25, and 25 µM) for 30 h. 1 x 105 cells/ml of WT and Grx1 KO 
cells were cultured in medium containing 100 µM Fe (III) (Iron(III) nitrate 
nonahydrate) for 48 h. In addition to induce a heat shock, 5 ml of 5 x 105 
cells/ml were transferred into 50 ml falcons and incubated in a water bath 
until the media reached temperature of 43 oC. This temperature was 
maintained for 15 or 30 min depending on the experiment. The temperature 
was monitored throughout the experiment by a digital thermometer 
(GT11700). Afterwards, viable cells were counted in a Neubauer chamber 
before the cells were re-transferred into normal culturing flasks. Recovery of 
the cells was then analysed at normal culturing conditions at 37 oC by counting 
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living cells at various time points. Cells not subjected to heat shock served as 
controls. 
 
2.2.13.3 Proliferation of bloodstream Grx1 KO cells at 39 °C 
As described in section 2.2.2, bloodstream WT and Grx1 KO clones are cultured 
in HMI-9 medium at 37 oC in a humidified incubator with 5 % CO2. Grx1 KO 
clones that harbor an ectopic copy of Grx1-c-myc2 are normally cultured in the 
presence of hygromycin. The proliferation of WT, Grx1 KO as well as Grx1 KO 
cells that express Grx1-c-myc2 (clones 2 and 3) was investigated at an elevated 
temperature of 39 oC. To induce overexpression of Grx1-c-myc2, the latter cells 
were cultured in the presence of 100 ng/ml tet, but without hygromycin. 
Uninduced clones were grown overnight also without hygromycin. WT cells in 
medium containing tet were used as controls. On the following day, cells were 
diluted in 5 ml pre-warmed at 39 oC to an initial starting density of 2 x 105 
cells/ml in culture flasks. The flasks cells were put into a 39 oC humidified 
incubator with 5 % CO2. After every 22 h, viable cells were counted and the 
cultures diluted back to the initial cell density. The induced cells were diluted 
always in 39 oC pre-warmed medium containing 100 ng/ml tet. Proliferation 
was monitored for a total of 110 h (Figure 16). Cells were harvested on the last 
day, boiled in reducing sample buffer containing 0.05 mg/ml DNase and stored 
at -20 oC for subsequent Western blot analyses. 
 
2.2.14 Phenotypic analyses of Grx2 knockout cell lines 
 
2.2.14.1 Phenotypic analyses of procyclic grx2 SKO clone compared to WT 
cells 
WT and grx2 SKO cells (in the presence or absence of puromycin) with an initial 
cell density of 2 x 105 cells/ml were grown in MEM-Pros at 27 oC. Cells were 
counted and diluted to initial cell density at time points 51, 96 and 144 h.  
 
2.2.14.2 Proliferation of procyclic Grx2 KO clones expressing an ectopic copy 
of Grx2 or mutant Grx2C34S compared to WT cells 
Grx2 KO procyclic cells harboring a tet-inducible ectopic copy of Grx2 or 
Grx2C34S mutant were overnight cultured in medium containing ±100 ng/ml 
tet, but with no hygromycin. As control, wildtype cells were also grown in the 
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presence of tet. On the following day, cells were diluted in 5 ml Mem-Pros 
medium to an initial density of 5 x 105 cells /ml and then cultured under 
normal conditions, counted after every 22 h and diluted to the initial starting 
cell density. Induced cells were always diluted in medium containing 100 ng/ml 
tet. Aliquots were harvested for Western blot analysis. 
 
2.2.14.3 Proliferation of bloodstream WT and Grx2 KO cells at 39 °C 
The proliferation of WT, Grx2 KO as well as Grx2 KO cells that express a tet-
inducible ectopic copy Grx2 was investigated at 39 oC as described in section 
2.2.13.3. 
 
2.2.15 Immunofluorescence microscopy 
WT, Grx1 KO and Grx2 KO cells grown at 39 oC as described above were 
harvested at time point 66 h for immunofluorescence analysis using DAPI, 
following the published procedure (Hiller et al., 2014). Kinetoplast and nuclear 
DNA analysis was done for at least 200 parasites for each clone in each 
experiment. 
 
2.2.16 Determination of redox state of glutaredoxins 
 
2.2.16.1 Modification of recombinant Grx1 with thiol reagents 
Recombinant T. brucei Grx1 was prepared following a published procedure 
(Ceylan et al., 2010) and stored at 4 oC. Five 100 µl samples containing 30 µM 
Grx1 in reaction buffer (50 mM Tris/HCl, 1 mM EDTA, 1% SDS, pH 7.5) were 
prepared and 25 µl ice-cold TCA solution (100 % TCA, 2 % HCl) was added. The 
mixtures were incubated on ice for 30 min, centrifuged at 13 000 rpm for 20 
min at 4 oC and the supernatants discarded. The pellets were washed three 
times with 200 µl ice-cold acetone and centrifuged. Each of the five pellets was 
then treated differently: (i) As a control, one Grx1 sample was dissolved in 100 
µl reaction buffer and stored at 4 oC. (ii) To alkylate the protein with AMS, the 
pellet was dissolved in 100 µl of 30 mM AMS dissolved in reaction buffer and 
incubated at 37 oC for 1 h. (iii) To alkylate the fully reduced protein with AMS, 
the pellet was dissolved in 100 µl reaction buffer containing 10 mM DTT and 
boiled for 5 min. The sample was TCA-treated, washed, dissolved in 100 µl 
reaction buffer containing 30 mM AMS and incubated for 1 h at 37 oC as 
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described above. (iv) To alkylate the fully reduced protein with NEM, the pellet 
was dissolved in 100 µl reaction buffer containing 10 mM DTT, boiled for 5 
min, TCA-precipitated and washed as outlined above. Afterwards, the pellet 
was dissolved in 100 µl reaction buffer containing 20 mM NEM and incubated 
for 30 min at room temperature in the dark. (v) To alkylate the fully reduced 
protein by NEM followed by AMS treatment, Grx1 was incubated with DTT, 
washed, reacted with NEM and washed again. The final pellet was dissolved in 
buffer containing 30 mM AMS and incubated at 37 oC for 1 h. 500 ng of each 
sample was subjected to SDS-PAGE on a  16 % gel under reducing conditions, 
run at a constant current of 15 mA and room temperature. The protein bands 
were visualized by silver staining. 
 
Figure 8. Scheme showing the modification of Grx1 by AMS or NEM. Grx1 has two 
cysteines in the active site and an additional one at position 78. (A) Reacting the stored 
recombinant protein with AMS results in the mono-modification of Cys78, resulting in a 
mass increase of about 500 Da compared to unmodified Grx1. (B) Fully reduced Grx1 
reacted with AMS will thus display a mobility shift of about 1500 Da. In contrast, blocking 
the cysteines with NEM prior to AMS treatment will not result in a mobility shift on the SDS 
gel as compared to unmodified Grx1. 
 
2.2.16.2 Modification of recombinant Grx2 with AMS 
Reaction buffer, TCA precipitation and washing procedures with acetone 
procedures used here were the same as in section 2.2.16.1. 
Three 100 µl samples containing 94 µM of recombinant Grx2 in reaction buffer 
were prepared and TCA-precipitated on ice for 30 min, centrifuged and the 
A 
B 
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supernatants discarded. The pellets were washed three times with ice-cold 
acetone, centrifuged and then treated differently: (i) As a control, one Grx2 
sample was dissolved in 100 µl reaction buffer (ii) To alkylate the protein with 
AMS, the pellet was treated as in procedure (ii) of section 2.2.16.1. (iii) To 
alkylate the fully reduced protein, the pellet was treated as in procedure (iii) of 
section 2.2.16.1. 500 ng of each protein was subjected to SDS-PAGE on a 16 % 
gel under reducing conditions, at a constant current of 15 mA and room 
temperature. The protein bands were visualized by silver staining. 
 
2.2.16.3 Determination of the in vivo redox state of Grx1 in bloodstream cells 
using AMS and/or NEM 
The reaction buffer and TCA solution used here were the same as in section 
2.2.16.1. Four samples each with 3 x 107 bloodstream cells harvested in 
logarithmic stage  at 2000 rcf for 10 min at 4 oC ,washed with 15 ml of PBS, 
resuspended in 1 ml PBS and transferred into Eppendorf cups. After 
centrifugation at 8000 rpm for 2 min at 4 oC, the supernatants were discarded. 
The cells were resuspended in 900 µl PBS and 100 µl ice-cold TCA was added. 
The mixtures were incubated on ice for at least 30 min and then centrifuged at 
13 000 rpm for 20 min at 4 oC. The protein precipitates were washed three 
times with 500 µl ice-cold acetone and then treated differently; (i) The control 
pellet was dissolved in 100 µl reaction buffer. (ii) The pellet was dissolved in 
100 µl reaction buffer containing 30 mM AMS and incubated for 1 h at 37 oC. 
(iii) The pellet was dissolved in 100 µl reaction buffer containing 20 mM NEM 
and incubated for 30 min at room temperature in the darkness. (iv)The pellet 
was dissolved in 100 µl reaction buffer containing 20 mM NEM and incubated 
for 30 min in the dark. 25 µl of ice-cold TCA was added. The sample was 
incubated for 30 min on ice and centrifuged at 13000 rpm at 4 oC for 20 min. 
The precipitate was washed three times with 500 µl ice-cold acetone and the 
final pellet was dissolved in 100 µl of 30 mM AMS and incubated at 37 oC for 1 
h. All samples were stored at 4 oC before analyses. 30 µl of each sample was 
mixed with 10 µl of reducing sample buffer, boiled for 5 min and 13.5 µl 
corresponding to approximately 3 x 106parasites was loaded per lane of a 16 % 
gel. The gel was subjected to SDS-PAGE followed by Western blot analyses 
using anti-Grx1 antibodies (1:800) (Figure 33). 
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2.2.16.4 Determination of the in vivo redox state of Grx1 in bloodstream 
form parasites under normal and oxidizing conditions 
Five samples each with 4 x 107 bloodstream cells in logarithmic growth phase 
were harvested and washed in PBS as in section 2.2.16.3.The cells were 
resuspended in 900 µl PBS and (i) 100 µl of ice-cold TCA was added, mixture 
was kept on ice, centrifuged and precipitate was washed with ice-cold acetone 
and then dissolved in 100 µl reaction buffer (for details, see section 2.2.16.3 ). 
(ii) TCA-precipitated and washed with acetone as in i. The pellet was dissolved 
in 100 µl reaction buffer containing 30 mM AMS and incubated for 1 h at 37 oC. 
(iii) 3 mM diamide was added (23 µl of 116.1 mM diamide stock in sterile 
water). The cells were incubated at room temperature for 5 min and 
centrifuged at 8000 rpm for 2 min at 4 oC. The cell pellet was resuspended in 
900 µl PBS and 100 µl of ice-cold TCA was added. The mixture was incubated 
on ice for at least 30 min and then centrifuged at 13000 rpm for 20 min at 4 oC. 
The precipitate was washed three times with 500 µl ice-cold acetone and the 
pellet reacted with AMS as described above. (iv) 3 mM diamide was added. 
The cells were incubated at room temperature for 5 min, centrifuged, 
resuspended in 900 µl of 37 oC pre-warmed HMI-9 medium and incubated for 5 
min. After centrifugation the cells were washed three times with 1 ml PBS. The 
proteins were precipitated and washed as described above and dissolved in 
100 µl reaction buffer. (v) treated with diamide and resuspended in medium as 
in (iv) except that the final pellet was additionally treated with AMS. In all 
cases, 30 µl of the cell extracts was mixed with 10 µl of non-reducing sample 
buffer, boiled for 5 min and 17 µl (corresponding to approximately 5 x 106 
parasites) was loaded per lane of a 16 % gel. The gel was subjected to Western 
blot analysis using the anti-Grx1 antibodies (1:800) overnight (Figure 34). 
 
2.2.16.5 In vivo redox state of Grx2 under normal and oxidizing conditions  
Six samples each with 4 x 107 procyclic cells in logarithmic growth phase were 
harvested, washed with PBS as in section 2.2.16.3. The cells were resuspended 
in 900 µl PBS and (i) the sample was treated the same as in procedure (i) of 
section 2.2.16.4. (ii) the sample was treated the same as in procedure (ii) of 
section 2.2.16.4. (iii) 3 mM diamide was added (23 µl of 116.1 mM diamide 
stock in sterile water). The cells were incubated at room temperature for 5 min 
and centrifuged at 8000 rpm for 2 min at 4 oC. The cell pellet was resuspended 
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in 900 µl PBS and 100 µl of ice-cold TCA was added. The mixture was incubated 
on ice for at least 30 min and then centrifuged at 13000 rpm for 20 min at 4 oC. 
The precipitate was washed three times with 500 µl ice-cold acetone and the 
pellet dissolved in 100 µl reaction buffer. (iv) treated with 3 mM diamide as in 
(iii) except that the final pellet was reacted with AMS as described  under (ii). 
(v) 3 mM diamide was added. The cells were incubated at room temperature 
for 5 min, centrifuged, resuspended in 900 µl of 27 oC pre-warmed MEM-Pros 
medium and incubated for 5 min. After centrifugation the cells were washed 
three times with 1 ml PBS. The proteins were precipitated and treated as 
described under (i). (vi) treated as in (v) except that the final pellet was  
treated with AMS. In all cases, 30 µl of the final solution was mixed with 10 µl 
of non-reducing sample buffer, boiled for 5 min and 34 µl (corresponding to 
approximately 1 x 107 parasites) was loaded per lane of a 16 % gel. The gel was 
subjected to Western blot analysis using the anti-Grx2 antibodies (1:200) 
overnight. 
 
2.2.17 Labelling of recombinant Grx2, Grx2C34S and 
Grx2C31S/C34S with AMS 
In a total volume of 50 µl reaction buffer (see section 2.2.16.1), 120 µg protein 
(Grx2, Grx2C34S or Grx2C31S/C34S) was incubated with 10 mM DTT for 20 min 
at 50 oC. 50 µl of 60 mM AMS in reaction buffer was added and the samples 
were incubated at 37 oC for 60 min. As controls, 120 µg of each protein was 
diluted in 100 µl reaction buffers. Afterwards, 33 µl of reducing sample buffer 
was added to each sample, boiled and samples stored at 4 oC. About 5 µg of 
each protein was loaded on a 16 % gel, subjected to SDS-PAGE and Coomasie-
stained afterwards.  
 
2.2.18 In vitro glutathionylation of T. brucei Grx1 
Recombinant Grx1 was prepared according to Ceylan et al., 2010. The protein 
concentration was determined at 280 nm (A280 of 1 corresponds to 1 mg/ml of 
pure Grx1). The thiol content was measured using Ellman’s reagent [5,5’-
dithio-bis-(2-nitrobenzoic acid),DNTB, (ε412 = 13.6 mM
-1cm-1) (Ellman, 1959). 1 
ml of 100 µM Grx1 in 100 mM potassium phosphate, 1 mM EDTA, pH 7, was 
incubated with 17.5 mM GSH and 13 mM diamide for 2 h at 25 oC. Excess 
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diamide and glutathione were removed by three buffer exchanges on a 10 kDa 
cut-off 15 ml Amicon ultra concentrator. The protein and thiol concentrations 
were measured again before the treated and untreated Grx1 samples were 
subjected to ESI-MS analyses. 
 
2.2.19 Determination of reductase activities of glutaredoxins 
 
2.2.19.1 HED assay 
The HED (hydroxyethyldisulfide) assay is a commonly used Grx-specific assay. 
During pre-incubation, HED is spontaneously reduced by glutathione forming  
mixed β-mercaptoethanol (β-ME) and a mixed disulfide between β-
mercaptoethanol and glutathione (β-ME and GSH) (Lillig et al., 2008). The 
mixed-disulfides is reduced upon addition of Grxs via a monothiol mechanism 
to produce β-ME and mixed disulfide between GSH and N-terminal active site 
cysteine of Grx. A second molecule of GSH then reduces the disulfide yielding 
GSSG. The reaction can be followed by measuring the NADPH consumption at 
340 nm by glutathione reductase (GR) during the reduction of GSSG (Lillig et 
al., 2008).  
 
Figure 9. Schematic diagram of the HEDS assay. GSH reacts spontaneously with HEDS (XS-
SX) resulting in the release of β-mercaptoethanol (XSH) and formation of a glutathione 
mixed disulfide (GS-SX). Grx catalyzes the release of a second β-mercaptoethanol molecule 
and gets glutathionylated (GS-Grx). Attack by a second GSH molecule restores free Grx and 
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generates glutathione disulfide (GSSG). The overall reaction is monitored 
spectrophotometrically at 340 nm as GSSG is reduced by glutathione reductase (GR) with 
the consumption of NADPH (Ceylan et al., 2010). 
 
2.2.19.2 Reduction of glutathione-mixed disulfide using glutaredoxins  
HEDS assay was carried out according to Ceylan et al., 2010. 1 ml of 100 mM 
potassium phosphate, 1 mM EDTA, pH 7, 200 µM NADPH, 1 mM GSH, 1 unit of 
GR, 0.015 - 1.25 mM HEDS were preincubated for 3 min at 25 oC  to form 
mixed disulfide between β-mercaptoethanol (HEDS) and glutathione. 
Reduction of the mixed disulfide was started by addition of 370 nM of either 
Grx1 or glutathionlyted Grx1 (glut-Grx1). NADPH consumption was measured 
at 340 nM. The deglutathionylation activities of the Grxs were calculated after 
subtraction of the background reaction. The experiment was carried out twice 
and in each experiment, reduction of mixed disulfide was measured twice at 
each HEDS concentration. The kinetic constants were obtained using the non-
linear regression SOLVER add-on in Microsoft Excel (Brown MA., 2000). 
In the case of Grx2 species, 2.5 mM HEDS was used and the reduction of the 
mixed disulfide was started by addition of 400 nM or 1 µM of Grx2, Grx2C34S 
or Grx2C31S/C34S. The experiment was carried out three times and in each 
experiment, reduction of mixed disulfide was measured twice.  
 
2.2.19.3 Insulin reduction assay 
The assay was performed according to Ceylan et al., 2010. In a total volume of 
200 µl reaction buffer (100 mM potassium phosphate, 2 mM EDTA, pH 7.0), 0.9 
µM tryparedoxin (Tpx), 9 or 22 µM of Grx2, Grx2C34S or Grx2C31S/C34S were 
incubated with 2.5 mM DTT (dithioerythritol) for 20 min at room temperature. 
The reaction was started by adding 600 µl of 1 mg/ml insulin in reaction buffer 
to resulting in a final concentration of 625 µM DTT and 131 µM insulin. The 
increase in turbidity was followed at 650 nm at 30 oC. 
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3 Results 
3.1 Both alleles of grx1 could be knocked out in procyclic 
cells 
Deletion of both grx1 alleles in procyclic cells was achieved by replacing one 
allele at a time. PCR analyses with a forward primer (Grx1-5utrFW_BM) binding 
upstream of the 5’untranslated region of grx1 used for recombination and a 
reverse primer specific for either blasticidin or puromycin (BlaRev and PuroR-
_BM2, respectively) verified the replacement of the grx1 alleles. Internal 
specific primers (Grx1 1Fo and Grx1 1Re) confirmed the presence of an allele in 
the SKO clones and the absence of any grx1 alleles in three selected KO clones 
(KO clones 1, 2, and 3) (for a scheme see Figure 6). As expected, a single 
knockout clone (SKO), but none of the KO clones yielded an amplicon with the 
two internal grx1 primers (Figure 10A). Primer combinations of Grx1-
5utrFW_BM/ BlaRev and Grx1-5utrFW_BM/PuroR_BM2 yielded for all three 
KO clones PCR products of 853 bp and 948 bp, respectively (Figures 10B and C), 
in accordance with insertion of the resistance cassettes at the correct locus. 
Total lysates of wildtype cells, a SKO clone and the three KO clones were 
subjected to Western blot analyses using anti-Grx1 antibodies (1:800 overnight 
incubation) and goat anti-guinea pig IgG-HRP (1:10000) as secondary 
antibodies. Grx1 was detected in both the wildtype cells and the SKO clones, 
but not in the three double knockout clones (Figure 10D). These results 
confirmed the successful replacement of both grx1 alleles. The double 
knockout (KO) clones were then cultured in MEM-Pros medium without any 
selecting antibiotics. 
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Figure 10. PCR and Western blot analyses of the procyclic WT and Grx1 KO cell lines. (A-C) 
PCR analyses with the primer combinations indicated above each graph with the expected 
fragment size in brackets. DNA from a single knockout (SKO) and wildtype (WT) cells served 
as controls. (D) Western blot analyses using anti-Grx1 antibodies (1:800). Total lysate from 2 
x 106 WT, a SKO clone and three KO clones was loaded per lane (14 % gel) as well as from 1 x 
107 cells in the case of the three KO clones. The results showed the absence of Grx1 in the 
three KO clones. A cross-reacting band at approximately 72 kDa served as loading control. 
(Clone 1 -C1 (1:4); Clone 2 - C4 (1:2); Clone 3 – C6 (1:2)). 
3.2 Bloodstream Grx1 KO cell line was obtained by a loss of 
heterozygosity 
The same strategy used in procyclic cells was applied in an attempt to replace 
the grx1 alleles in bloodstream form cells. However, single knock out clones 
could only be obtained upon selection with blasticidin and not with puromycin. 
After culturing the SKO cells in the presence of 5 µg/ml blasticidin for several 
weeks, Western blot analyses were performed to determine the Grx1 level in 
the mutant compared to that in WT cells. Surprisingly, no Grx1 could be 
detected in the supposed SKO cells. Thus, I extracted DNA from these cells for 
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PCR analyses. The primer pair Grx1-5utrFW_BM/BlaRev gave the expected PCR 
product of 853 bp. However, Grx1 1Fo/Grx1 1Re did not yield a fragment of 
193 bp which would have been expected in the case of a remaining grx1 allele. 
These cells were then defined as double knock out clones (KO). I then thawed 
the SKO cells that had been frozen directly after the replacement of the first 
allele by the blasticidin resistance gene as previously verified by PCR analysis 
(not shown). Indeed, PCR analyses revealed amplicons for both Grx1-
5utrFW_BM/ BlaRev and Grx1 1Fo/Grx1 1Re primer combinations (Figure 11A). 
These results confirmed the loss of heterozygosity in these bloodstream cells 
by long-term cultivation in the presence of blasticidin. Western blot analyses 
using antibodies against Grx1 revealed the protein in wildtype cells and the 
original single knockout cells but not in the double knockout cells (Figure 11B). 
 
 
Figure 11. Grx1-deficient bloodstream form T. brucei obtained by a loss of heterozygosity. 
(A) PCR analyses using the indicated primer combinations with the expected sizes in 
brackets confirmed the replacement of the grx1 alleles. SKO DNA was extracted from cells 
that had been frozen directly after successful replacement of one grx1 allele by the bla 
resistance gene. KO DNA was extracted from those cells after cultivation in the presence of 
5 µg/ml blasticidin for several weeks. WT DNA served as control. PCR with PxII (glutathione 
peroxidase-type tryparedoxin peroxidase) internal primers (specific for PxII) served as 
positive control. (B) Western blot analyses with the anti-Grx1 (1:800) antibodies revealed 
the absence of protein in the double-knockout cell line. The membrane was stripped and re-
probed for 2-Cys-peroxiredoxin (TXNPx 1:6000) as a loading control. 
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3.3 Phenotypic analyses of procyclic Grx1 KO cells  
To investigate a putative role of Grx1 in the overall protection of the parasites 
against oxidative stress, procyclic WT and Grx1 KO cells (clone C1 (1:4)) (KO 
clone1 in Figure 10) were cultured in the presence of diamide or hydrogen 
peroxide as described in section 2.2.13.1. No difference in the sensitivity 
between the wildtype cells and the Grx1 KO clone was observed (Figures 12 A 
and B). At a concentration of 100 µM neither iron (II) nor iron (III) had any 
effect on the proliferation of the WT and Grx1 KO parasites (Figure 12C). There 
was also no difference in the proliferation when deferoxamine, an iron (III) 
chelator (Breidbach et al., 2002) was used. WT and KO cells displayed the same 
sensitivity (Figure 12D). There was also no difference in the recovery of 
proliferation after a heat shock at 41 oC between the WT and KO cells (Figure 
12E). Thus, for none of the stressors studied, a proliferation defect could not 
be observed for the Grx1 KO procyclic cell line compared to WT cells. 
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Figure 12. Proliferation of procyclic Grx1 KO cells compared to WT cells in the presence of 
exogenous stressors and upon heat shock treatment. 5 x 105 cells/ml of WT and Grx1 KO 
cells were cultured at 27 oC in the presence or absence of  (A) 20 µM diamide, (B) 2.5, 5 and  
10 µM H2O2, (C) 100 µM Fe(II) or 100 µM Fe(III), and (D) 25 , 100 and 500 µM deferoxamine 
(Df). The stressors were added once at time point zero. (E) 5 x 105 cells/ml WT andGrx1 KO 
cells were incubated for 60 min at 41 oC, viable cells were counted and the culture was put 
back to 27 oC. Control cells were not incubated at 41 oC, but kept at 27 oC from time point 0 
h (inset, enlargement of the 0 to 6 h data). Viable cells were counted at various time points 
in a Neubauer chamber. The data are the mean ± standard deviation of three independent 
experiments. 
 
E 
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3.4 Phenotypic analyses of Grx1 KO bloodstream T. brucei 
Deferoxamine, iron (III) and heat shock were also studied as stresses of WT and 
Grx1 KO bloodstream cells. As in procyclic cells (Figure 12), no differences in 
the proliferation could be detected between the WT and mutant cells (Figure 
13 A-C). Grx1 does not seem to play a role in protecting bloodstream parasite 
cells from iron depletion by deferoxamine or a 43 oC heat shock.  
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Figure 13. Proliferation of bloodstream WT and Grx1 KO cells subjected to various 
stresses. (A)  5 x 105 cells/ml WT and Grx1 KO parasites were grown in the presence of 
different concentrations of deferoxamine.(B) Cumulative cell density of WT and Grx1 KO 
cells with an initial cell density of 1 x 105 cells/ml grown in presence of 100 µM iron (III). (C) 
5 x 105 cells/ml WT and Grx1 KO parasites were incubated at 43 oC for 15 or 30 min and 
returned to 37 oC. The values are the mean ± standard deviation of three independent 
experiments. 
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3.5 Grx2 expression levels are not affected by the deletion 
of Grx1 in bloodstream parasites 
Since no proliferation defect could be detected in the Grx1 KO cell lines, the 
expression of Grx2, the other dithiol glutaredoxin of the parasite, was 
investigated. Western blot analyses using the anti-Grx2 antibodies (1:200) 
showed that the Grx2 levels were virtually the same in both cell lines (Figure 
14). Thus, the two dithiol glutaredoxins do not appear to exert redundant 
physiological roles. This is supported by their different subcellular localization. 
Grx1 and Grx2 were found in the cytosol and mitochondrion, respectively 
(Ceylan et al., 2010).  
 
     
Figure 14. Grx2 expression is not affected in bloodstream Grx1 KO parasites. 2 x 107 
wildtype and grx1-KO bloodstream parasites were subjected to Western blot analyses using 
the anti-Grx1 (1:800) and anti-Grx2 antibodies (1:400).The results show that there is no 
upregulation of Grx2 in the Grx1 KO cells. 
3.6 Bloodstream Grx1 KO cells had a growth advantage at 
39 oC compared to WT cells 
WT and Grx1 KO cells multiply 13 fold within 22 h when grown at 37 oC 
(doubling every 6 h). Initial experiments had shown that Grx1 KO clones like 
WT cells, had growth retardation at 39 oC as compared to normal temperature 
of 37 oC. However, the Grx1 KO clone had a slight growth advantage compared 
to WT cells at 39 oC. To confirm that this improved proliferation was indeed 
due to the absence of Grx1, I transfected Grx1 KO cells with an ectopic copy of 
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Grx1-c-myc2. Overexpression of Grx1-c-myc2 (clones 2 and 3) was achieved by 
culturing the cells overnight at 37 oC in medium containing 100 ng/ml tet. The 
Western blot analyses with the anti-Grx1 antibodies (1:600) showed for both 
clones a leaky expression of Grx1-c-myc2 (Figure 15). At 39 
oC, the Grx1 KO 
clone displayed a slight growth advantage compared to WT cells, whereas the 
KO cells expressing Grx1-c-myc2  proliferated like WT cells (Figures 16A and B). 
The results confirmed that the growth advantage observed in the Grx1 KO 
clone was due to the absence of the protein and suggests that Grx1 may play a 
role in the proliferation control of bloodstream parasites at elevated 
temperatures. The average multiplication times during different 22 h time 
periods of continuous growth (diluting to initial cell density after every 22 h) 
for WT (- tet) and Grx1 KO cells at 39 oC (from 3 different experiments) are 
given in Figure 16 C. Immunoflourescence of DAPI-stained WT and Grx1 KO 
cells grown until 66h at 39 oC showed that the Grx1 KO cells had more normal 
cells with 1 kinetoplast and 1 nucleus compared to WT cells. The number of 
‘multiple cells’, those with at least 2 kinetoplast and 2 nuclei were lower in the 
Grx1 KO cells compared to WT cell as summarized in the table in  Figure 16 D 
as percentages of total populations counted. The number of cells which had 
lost kinetoplast or with one kinetoplast and 2 nuclei were similar for both cell 
lines. 
 
                                                                                                                                                                                       
Figure 15. Western blot analyses against Grx1 of bloodstream WT and Grx1 KO cells 
expressing an ectopic copy of Grx1-c-myc2. Overexpression of Grx1-c-myc2 was achieved by 
culturing the cells overnight in medium containing 100 ng/ml tet, but without hygromycin. 
Uninduced cells were grown overnight without any selecting antibiotics. Cell extracts were 
loaded on a 14 % SDS gel under reducing conditions and subjected to Western blot analyses 
using the anti-Grx1 (1:600) antibodies overnight. lane 1, 4 x 106 WT cells. lane 2, 1 x 107 WT 
cells. lane 3, 4 x 106 Grx1 KO cells (clone 2) harboring an ectopic copy of Grx1-c-myc2 
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(without tet). lane 4, 1 x 107 Grx1 KO cells (clone 3) harboring an ectopic copy of Grx1-c-
myc2 (without tet).  
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Figure 16. Proliferation of bloodstream cell lines at 39 oC. WT, Grx1 KO and Grx1 KO clones 
expressing Grx1-c-myc2 (+/- 100 ng/ml tet) were cultured at 39 
oC. WT cells were also 
cultured in presence of tet as control. The cells had an initial density of 2 x 105 cells/ml in 5 
ml of 39 oC pre-warmed HMI-9 medium. After every 22 h, living cells were counted and the 
culture was diluted to the initial cell density. (A) A representative graph showing the 
proliferation at 39 oC for the different cell lines as percentage of starting density. There was 
a significant difference in the proliferation between WT and Grx1 KO cells from time point 
66 to 110 h, indicated by * (p value < 0.05, calculated using Microsoft Excel student’s 
unpaired t-test with equal variance). (B) Cumulative cell density for the different cell lines up 
to time point 110 h. (C) Average multiplication time of WT and Grx1 KO cells at the 22 h 
intervals indicated. The results are the mean ± standard deviation of three independent 
experiments. (D) Immunofluorescence analysis WT and Grx1 KO cells grown at 39 oC. WT 
and Grx1 KO cells grown at 39 oC were harvested at time point 66 h for immunofluorescence 
analysis using DAPI stain to visualize kinetoplast (K) (with smaller dots) and nucleus (N) with 
(large dots), shown on lower panel. The phase contrast pictures are shown on the upper 
panel (scale bar:10 µm). Analysis of the different phenotypes observed as percentages are 
C 
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summarized in the table (right). At least 200 parasites were analyzed for each cell line and 
the results are the mean ± standard deviation of three independent experiments. 
3.7 Cys78 of Grx1 is susceptible to in vitro glutathionylation 
Reacting stored recombinant T. brucei Grx1 with Ellman’s reagent yielded a 
protein to thiol ratio of 1:1. Thus only one cysteine reacted per protein 
molecule most probably because the active site thiols become oxidized upon 
storage. Incubation of the Grx1 sample with GSH and diamide resulted in a 
protein species without any free thiol. Treated and untreated Grx1 samples 
were subjected to ESI-MS analyses. The GSH/diamide treated Grx1 revealed a 
total mass of 11.135 kDa in comparison to 10.831 kDa for the untreated 
control (Figures 17 A and B). The mass increase of 304 Da is consistent with the 
addition of one GSH molecule. Most probably the glutathionylated residue is 
Cys78. Even if the active site disulfide became transiently reduced by GSH and 
Cys21 glutathionylated upon GSH/diamide treatment, the adjacent Cys24 
should immediately displace the GSH to regenerate the intramolecular 
disulfide (Beer et al., 2004). This third cysteine is conserved in the Grx1 
sequences of Leishmania major (Ceylan et al., 2010), human and T. vivax 
(TvY486_1101340) (Figure 18) as well as E. coli Grx3 which may suggest a 
putative regulatory function in the parasite oxidoreductases. 
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Figure 17. In vitro glutathionylation of Grx1. 100 µM Grx1 was incubated with 17.5 mM 
GSH and 13 mM diamide for 2 h at 25 oC. After removal of excess diamide and GSH, the 
Grx1 samples were subjected to ESI-MS analyses (Thomas Ruppert, ZMBH). (A) The 
GSH/diamide treated protein revealed a total mass of 11.135 kDa in comparison to 10.831 
kDa of unmodified Grx1 (B). The mass increase by 304 Da is consistent with the addition of 
one GSH molecule, most probably at Cys78.  
 
 
 
 
A 
B 
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T. vivax 1       -------------MNS-LAAIIGSARVVVLSWVTCPYCVRAEKLLKQLTDE---VKVYYV 43 
T. brucei 1      -------------MPS-IASMIKGNKVVVFSWVTCPYCVRAEKLLHARTKD---ITVHYV 43 
L. major 1       MFSSRFLYRSSSTMPATVAELITQHKVVVFSWVHCPYCSRAKEILKSLAKD---IQVYEC 57 
E. coli 3        ------------------------ANVEIYTKETCPYCHRAKALLSSKGVS---FQELPI 33 
Human 1          ------------MAQEFVNCKIQPGKVVVFIKPTCPYCRRAQEILSQLPIKQGLLEFVDI 48 
                                          .* :     **** **: :*     .   .      
 
T. vivax 1       DKMPEGEELRREVFREYHHETVPAIFINKNFVGGCSDLEDLQRDGKLAELLK------ 95 
T. brucei 1      DKMSEGEQLRGEIYQAYKHETVPAIFINGNFIGGCSDLEALDKEGKLDGLLS------ 95 
L. major 1       DQMDNGEELRTQILQAYNHDTVPAIFINGEFIGGCSDLQAIQKSGELAAKLA------ 109 
E. coli 3        DGN---AAKREEMIKRSGRTTVPQIFIDAQHIGGCDDLYALDARGGLDPLLK------ 82 
Human 1          TATNHTNEIQDYLQQLTGARTVPRVFIGKDCIGGCSDLVSLQQSGELLTRLKQIGALQ 106 
                          :  : :     *** :**. : :***.**  ::  * *   *                         
 
Figure 18. Comparison of T. brucei glutaredoxin 1 with Grxs of other organisms. T. brucei 
has two cysteines in the active site (highlighted by a yellow background) and an additional 
one at position 78 (highlighted in red) which is conserved in glutaredoxins of T. vivax 
(Trypanosoma vivax,TvY486_1101340), L. major (Leishmania major, LmjF.27.0810), E. coli 
(Aslund et al., 1996)and human (sp|P35754|GLRX1_HUMAN Glutaredoxin-1) 
 
3.8 Glutathionylated Grx1 had a diminished reductase 
activity 
The effect of gluathionylation of non-active site of Grx1 on reducing 
glutathione-protein mixed disulfides compared to unmodified Grx1 was 
investigated using the HED assay (see section 2.2.19 for method). Results 
showed that the glut-Grx1 had reductase activity that was three-fold lower 
compared to unmodified Grx1. However glut-Grx1 had a lower Km value which 
resulted in the same kcat/Km values (Table 7). 
Table 7. Reduction of mixed disulfide between β-mercaptoethanol and GSH 
by Grx1 or glut-Grx1 
Protein Vmax (U/mg) Km  
(µM) 
kcat  
(s-1) 
kcat/Km 
 (M
-1s-1) 
Grx1 4.7 ± 0.1 53 ± 5 0.84 ± 0.02 (1.6 ± 0.1) x 104 
glut-Grx1 1.6 ± 0.1 13 ± 3 0.30 ± 0.01 (2.3 ± 0.2) x 104 
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3.9 Grx2 is essential in procyclic cells and has got a redox 
function 
 
3.9.1 Only a single grx2 allele could be deleted in procyclic cells 
Using the strategy depicted in Figure 7, grx2 SKO cells could be obtained in 
procyclic cells. However, an attempt to replace the second allele in the SKO 
cells resulted in a double-resistant clone that still kept a grx2 allele as shown 
by both PCR and Western blot analysis (Figure 19A and B). Western blot 
analysis revealed that the amount of Grx2 expressed in the grx2 SKO clone was 
lower as compared to WT cells (Figure 19B). To get an insight if the diminished 
Grx2 have an effect on the proliferation, the proliferation of grx2 SKO clone 
was compared to wildtype cells. The grx2 SKO clone displayed a slight 
proliferation defect as compared to WT cells (Figure 19C) in accordance to with 
the previous data obtained by Ceylan et al., 2010 showing that RNAi against 
Grx2 results in a proliferation defect. However, remarkably, after several 
months in culture, the proliferation defect was lost (not shown) and Western 
blot analysis showed that the grx2 SKO clone had a Grx2 level comparable to 
that in WT cells (Figure 19D). 
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Figure 19. Deletion of both grx2 alleles was not possible in procyclic cells. (A) PCR analyses 
using the indicated primer combinations with the expected sizes in brackets confirmed the 
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insertion of the two resistance genes at the correct positions. However, the double-resistant 
cells still displayed a grx2 gene. 1,DNA from WT, 2, a SKO clone, and 3, a double-resistant 
clone. (B) Total lysates from procyclic cells revealed a decreased protein level in the grx2 
SKO cells (lane 2) as compared to WT cells (lane 1).The double-resistant cell line expressed 
Grx2 (lane 3). Total lysates from 1 x 107 cells were loaded per lane and subjected to SDS-
PAGE on a 14 % gel followed by Western blot analyses using anti-Grx2 antibodies (1:200). 
(C) WT and Grx2 SKO cells (+/- puromycin) with an initial cell density of 2 x 105 cells/ml were 
grown in MEM-Pros at 27 oC and diluted to initial cell density at time points 51 h, 96 h and 
144 h. left, The cumulative cell density shows a slight proliferation defect in the SKO cells 
compared to WT cells. The results are the means ± standard deviation of three different 
experiments. right, A representative graph showing the proliferation of the WT and SKO cell 
lines as a percentage to starting cell density. (D) After a few months in culture, the procyclic 
grx2 SKO cells expressed Grx2 at nearly WT levels. Total lysates from 5 x 106 or 2 x 107 WT 
and SKO cells were loaded on a 14 % gel and subjected to Western blot analysis with the 
anti-Grx2 antibodies (1:200). The membrane was re-probed for TXNPx (1:3000) which 
served as a loading control. 
 
3.9.2 Both grx2 alleles could be deleted in procyclic cells expressing an 
ectopic copy of Grx2 or Grx2C34S  
In the presence of tetracycline to express the ectopic copy of Grx2, procyclic 
clones were obtained that had both the puromycin and neomycin resistance 
genes in the correct locus as shown by PCR analysis (Figure 21A). Internal 
primers for grx2 could not be used to confirm the deletion of the grx2 alleles, 
since they would also amplify the grx2 from the ectopic copy. Thus, primers 
were designed that in combination with grx2-specific primers would amplify 
the authentic gene, but not the ectopic grx2 (depicted in Figure 20). The 
5UTRGrx2-2F_BM primer binds 5 bp before the grx2 coding region and the 
3UTRGrx2_2R_BM binds 13 bp after the stop codon. PCR analyses with the 
primer combinations 2CGrx2F_BM /3UTRGrx2_2R_BM and 5UTRGrx2-2F_BM 
/2CGrx2R_BM showed amplicons for the WT cells, but not for the inducible KO 
cells (Figure 21B).The obtained clones were then cultured in the presence or 
absence of tetracycline. Surprisingly, the inducible grx2 KO clones survived 
even in medium lacking tetracycline. Western blot analysis revealed expression 
of protein.This indicates that the inducible expression system became leaky 
after tet removal in cells lacking the authentic grx2 alleles (Figure 22).The 
inducible system was perfectly tight in the SKO background (not shown). 
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Figure 20. Scheme for the primers specific for authentic grx2. To confirm the deletion of 
the authentic grx2 alleles in the inducible procyclic Grx2 KO cells, two new sets of primers 
were used. The primer pairs result in an amplicon for the authentic gene, but not for the 
ectopic copy which does not contain any parts of either the 5’- or 3’-untranslated regions. 
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Figure 21. PCR analyses of the inducible grx2-deficient procyclic cell lines  expressing an 
ectopic copy of wildtype Grx2. (A ) PCR analyses using the indicated primer combinations 
with the expected sizes in brackets confirmed the insertion of the two resistance genes in 
the grx2 locus in the presence of a tet-inducible ectopic copy of wildtype Grx2. The faint 
lower bands seen are a result of a second binding site of the forward primer. (B) Primer 
combinations that distinguish the authentic grx2 gene from ectopic grx2 gene showed that 
both grx2 alleles were replaced in the presence of an ectopic copy of wildtype Grx2. WT 
DNA served as control. For the primer sequences and binding sites see Table 2B and Figure 
7, respectively.  
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Figure 22. The inducible procyclic Grx2 KO cells express Grx2 independent of tet. Procyclic 
WT and two Grx2 KO clones harboring an ectopic copy of the grx2 gene were transferred 
into MEM-Pros without tetracycline. After one week, cells were harvested and total lysates 
of 2 x 107 cells were loaded on a 14 % gel and subjected to Western blot analysis using the 
anti-Grx2 antibodies (1:200).Both Grx2 KO clones (1 and 2) expressed the ectopic Grx2 to at 
least wildtype-like levels and which explains why these clones could survive without 
induction.  
 
3.9.3 Grx2 has a redox function in procyclic cells 
As it was not possible to control the expression of ectopic Grx2 in the inducible  
Grx2 KO cells, I investigated if in the procyclic cells Grx2 has a redox function 
requiring one or both of its active site cysteines at positions 31 and 34 (Figure 
23).The previously generated grx2 SKO cells were transfected with constructs 
to express tet-inducible ectopic copies of either Grx2C34S or Grx2C31S/C34S.  
Afterwards, I attempted to delete the second grx2 allele in these cells in the 
presence of tet. I was successful in deleting both grx2 alleles in cells expressing 
an ectopic copy of Grx2C34S as confirmed by PCR (Figures 24 A and B).Western 
blot analysis showed that the clones also had leaky expression of ectopic 
Grx2C34S (Figure 25C). The inducible system was perfectly tight in the SKO 
background (not shown). An attempt to delete both grx2 alleles in cells 
expressing an ectopic copy of Grx2C31S/C34S was not successful as the 
double-resistant clones kept the grx2 genes. These results showed that Grx2 
has a redox function that requires at least the cysteine at position 31.  
 
T. brucei_Grx2       MNNALDPAKAPQFLDMMLRRNKMVMVSATYCQFCTKLKMLLIELKHRFVSLEIDIIPNGR  
T. cruzi_Grx         MNKALDPAKAPQFLDMMLRRNQIVLISATYCEYCTKLKMLLIEMKHRFVSLEINIIPNGR  
L. major_Grx2        MNQVLDPARAPQFLDSMLRRNRIVLISATYCQFSTKLKMLLIELKHRFVSLEIDIIPNGR  
                     **:.****:****** *****::*::*****::.*********:*********:******  
 
T. brucei_Grx2       EVFAEVVGRTGVHTVPQVFLNGKYFGGYDELVAMYRAGHLSAEIERG  
T. cruzi_Grx         EVFAEVVGRTGVHTVPQMFHNGKYLGGYDEIVALYRRGELSATLERR  
L. major_Grx2        EVFQEVVARTGVHTVPQVFLNGKYLGGYDDLIALYHKRELSETLEKR  
                     *** ***.*********:* ****:****:::*:*:  .**  :*: 
Figure 23. Protein alignments of the Grx2-type proteins from T. brucei, T. cruzi and 
Leishmania major. Grx2 (Tb 927.1.1770) of T. brucei has about 80 % similar sequence to 
that of T. cruzi (TcCLB.511431.40) and L. major (LmjF.20.1010) (Ceylan et al., 2010). The 
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active site cysteines are highlighted by a red background. Interestingly, the L. major Grx2 
has a monothiol active-site unlike those of T . brucei and T. cruzi which have two active-site 
cysteines. 
 
 
 
Figure 24. PCR analyses of the inducible grx2-deficient procyclic cell lines expressing an 
ectopic copy of Grx2 C34S mutant. (A) PCR analyses using the indicated primer 
combinations with the expected sizes in brackets confirmed the insertion of the two 
A 
B 
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resistance genes in the grx2 locus in the presence of a tet-inducible ectopic copy of 
Grx2C34S mutant. (B) Primer combinations that distinguish the authentic grx2 gene from 
ectopic grx2 gene showed that both grx2 alleles were replaced in the presence of an ectopic 
copy of Grx2 C34S mutant. WT DNA served as control. 
 
3.9.4 Procyclic Grx2 KO clones that express an ectopic copy of Grx2C34S 
mutant had a slight proliferation defect 
When grown in MEM-Pros medium at 27 oC, WT cells showed the same 
proliferation as the Grx2 KO clones expressing a wildtype ectopic copy of Grx2 
(clone D1 (1:2)) both in the absence or presence of tet. In comparison, three 
different Grx2 KO clones that expressed the Grx2C34S mutant (clone 1 - 
B5(1:2), clone 2 - C6(1:4) and clone 3- D2(1:20)) had a slight proliferation 
defect as compared to wildtype cells (Figure 25 A). The doubling times for each 
type of cell lines were very similar in the presence or absence of tet, so I 
averaged the doubling times obtained +/- tet each obtained from three 
different experiments (Figure 25B). Western blot analyses revealed that all the 
inducible cell lines expressing the ectopic copies of Grx2 (either wildtype or 
mutant) had leaky protein expression that was at least of wildtype-like levels 
(Figure 25C). Overexpression of the ectopic Grx2 proteins (wildtype or 
mutants) by tet-induction in the procyclic Grx2 KO clones did not affect the 
proliferation. 
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Figure 25. Procyclic Grx2 KO clones expressing an ectopic copy of Grx2C34S had a slight 
growth defect as compared to wildtype cells or Grx2 KO cells expressing wildtype Grx2. (A) 
Wildtype, Grx2 KO cells expressing ectopic copies of either Grx2 or Grx2C34S mutant ectopic 
C 
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copies (+/- tet) with an initial density of 5 x 105 cells/ml were grown in MEM-Pros medium 
at 27 oC and diluted to the initial cell density after every 22 h. left, Cumulative cell density 
for the different cell lines up to time point 110 h. The values are the mean ± standard 
deviation of three independent experiments. right, A representative graph showing the 
proliferation of the different cell lines as a percentage to starting cell density. (B) The 
average doubling times for the different cell lines were calculated after every 22 h in each 
experiment. The doubling times for each cell line (+/- tet) were very similar and thus 
summarized together in the analysis. The results are the means ± standard deviation of 
three different experiments. (C) Aliquots were harvested for Western blot analysis after 
dilution to initial density at every time. Shown here is a representative blot with  extracts 
from 1.4  x 107 cells from experiment 3 (time point 88 h) loaded on a 14 % SDS gel and 
subjected to Western blot analysis using the anti-Grx2 antibodies (1:200).  1 – WT cells, 2 
and 3 - Grx2 KO cells expressing the ectopic Grx2C34S mutant (clone 2 and 3, respectively),  
4 - Grx2 KO cells expressing an ectopic copy of wildtype Grx2. All cell lines were grown in the 
absence or presence of 100 ng/ml tet. The membrane was re-probed for TXNPx which 
served as a loading control. 
 
3.9.5 Recombinant C34S Grx2 lacks protein disulfide reductase activity 
The Grx2 KO cells harboring an ectopic copy of Grx2C34S were able to 
proliferate. I therefore investigated the possible role of Grx2C34S to reduce 
protein disulfides. Recombinant Grx2C31S/C34S and Tpx protein served as 
negative and positive controls, respectively. For method see section 2.2.19.3. 
0.9 µM Tpx rapidly reduced insulin as expected (Ceylan et al., 2010). Amongst 
the Grxs species, Grx2 showed the highest activity. Surprisingly, 
Grx2C31S/C34S displayed also some activity, but the Grx2C34S mutant did not 
have any activity (Figure 26 A). The results indicate that both Grx2 and 
Grx2C34S might not play a role in the reduction of protein disulfides in the 
parasites as Grx2 KO parasites expressing an ectopic copy of Grx2C34S are fully 
viable. The activity of the Grx2C31S/C34S might have been caused by a 
contamination, most probably from some a small amount of thioredoxin which 
is part of the fusion protein that is then removed by TEV digest. To rule out 
that the protein samples which were purified at the same time were mixed up, 
I confirmed their identity by AMS labeling. 
Labelling of one cysteine residue of a protein with AMS causes a mobility shift 
500 Da compared to the unmodified protein. Silver staining results had 
previously revealed that both cysteines of Grx2 can be labeled (not shown). 
Thus, a reduced Grx2 should result in a mobility shift of 1000 Da in contrast to 
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Grx2C34S which should only result in a mobility shift of 500 Da and 
Grx2C31S/C34S should not show any shift as it does not contain any cysteine. 
Results shown in Figure 26B confirmed the identity of the three recombinant 
proteins used in the insulin assay. Recombinant Grx2C31S/C34S was not stable 
as it precipitated in the tube. This might also be the reason why some activity 
was displayed by this recombinant protein in the assay. 
 
Figure 26. (A) Reduction of insulin by recombinant Grx2, Grx2C34S and Grx2C31S/C34S. 
The reduction of insulin was followed by measuring the turbidity at 650 nm. In a total 
volume of 800 µl (100 mM potassium phosphate, 2 mM EDTA, pH 7.0), the reaction 
mixtures contained no putative reductase (control), 0.9 µM Tpx, 9 or 22 µM of Grx2, 
Grx2C34S or Grx2C31S/C34S, 625 µM DTT and 131 µM insulin. The increase in turbidity was 
followed at 650 nm at 30 oC. The graph shown here is a representative of the experiment 
performed three times.(B) Reaction of recombinant Grx2 species with AMS. 120 µg of 
Grx2, Grx2C34S and Grx2C31S/C34S were treated with 10 mM DTT and then reacted with 
30 mM AMS as outlined under Materials and Methods (section 2.2.17). 5 µg of each sample 
was loaded onto a 16 % gel under reducing conditions and subjected to SDS-PAGE and 
subsequently visualized by coomasie-staining. 1- untreated controls, 2- samples treated 
with DTT and AMS. Labelling of maximum of 2 or 1 cysteines by AMS confirmed the identity 
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of Grx2 and Grx2C34S, respectively. There was no mobility shift in the sample treated with 
AMS (lane 6) compared to untreated sample (lane 5), confirming the identity of 
Grx2C31S/C34S. The lower bands in lanes 2 and 4 were due to incomplete labeling of the 
cysteines by AMS. 
 
3.9.6 Grx2 and Grx2C34S have deglutathionylation activity 
Protein deglutathionylation catalyzed by Grxs proceeds via a monothiol 
mechanism involving the N-terminal cysteine of the active site (Lillig et al., 
2008). Since the Grx2 KO procyclic cells proliferated if they expressed an 
ectopic copy of either Grx2 or the Grx2C34S mutant, I compared the 
deglutathionylation activity of recombinant Grx2 and Grx2C34S in the HED 
assay. Recombinant Grx2C34S catalyzed the reaction with 35 % of the wildtype 
Grx2 activity. The double cysteine mutant, Grx2C31S/C34S, did not have any 
deglutathionylation activity (Figure 27). Thus, Grx2 and Grx2C34S might be 
involved in deglutathionylation reactions in the procyclic cells. 
    
Figure 27.The activities of recombinant Grx2 species in the HEDS assay. In a total volume of 
1 ml of 100 mM potassium phosphate, 1 mM EDTA, pH 7.0, 200 µM NADPH, 1 mM GSH, 1 U 
of human GR and 2.5 mM HEDS (2-hydroxyethyl disulfide) were incubated for 3 min at 25 
oC. The reaction was started by addition of 400 nM of Grx2, Grx2C34S or Grx2C31S/C34S 
and NADPH consumption was measured at 340 nm. None is the background activity without 
any Grx. Grx2C34S had about 35 % activity compared to wildtype Grx2. Grx2C31S/C34S  
displayed an activity similar to the background (none). The data are the mean ± standard 
deviation of three independent experiments. 
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3.10 Both grx2 alleles could be knocked out in bloodstream cells 
Using the strategy depicted in Figure 7, grx2 SKO of bloodstream parasites 
were stepwise obtained. SKO clones from the first transfection were then used 
to generate grx2 KO cell lines by transfecting them with the other deletion 
cassette. PCR analysis (Figure 28A) confirmed the replacement of both alleles. 
WT and grx2 SKO DNA served as controls. The absence of the grx2 alleles was 
further confirmed by Western blot analysis (Figure 28B), with WT and Grx2 
SKO clone serving as controls.  
   
           
Figure 28. Grx2 deficient bloodstream form T. brucei. (A) PCR analyses using the indicated 
primer combinations with the expected sizes in brackets confirmed the replacement of the 
grx2 alleles. 1, 2 and 3 are the PCR products from WT, SKO clone and Grx2 KO clones 
respectively. (B) Western blot analyses with the anti-Grx2 (1:200) antibodies revealed the 
presence of the protein in the wildtype and Grx2 SKO cells but not the double-knockout cell 
line. Total lysates from 2 x 107 cells were loaded per lane.  
A 
B 
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To get an insight if in the grx2-deficient cells, Grx1 might be overexpressed, the 
levels of the cytosolic Grx1 in the Grx2 KO cells was compared with that in 
wildtype cells. Western blot analysis did not reveal any upregulation of Grx1 in 
Grx2 KO clone compared to wildtype cells (Figure 29). The membrane was re-
probed for TXNPx which served as a loading control. 
         
Figure 29. Grx1 expression is not affected in bloodstream Grx2 KO parasites. Total lysates 
of 1 x 107 wildtype and Grx2 KO bloodstream parasites were loaded on a 14 % SDS gel and 
subjected to Western blot analyses using the anti-Grx1 (1:800) antibodies. The membrane 
was re-probed for 2-Cys-peroxiredoxin (TXNPx 1:6000) as a loading control. There was no 
upregulation of Grx1 in Grx2 KO cell line compared to WT bloodstream cells. 
3.11 At 39 oC, bloodstream Grx2 KO cells proliferate better 
than the wildtype cells 
When cultured at 39oC, Grx2 KO had a proliferation advantage compared to 
WT as was seen in section 3.6 for Grx1 KO cells. However, Grx2 KO cells had 
the greatest proliferation advantage at 39 oC (compared to WT and Grx1 KO 
from time point 44 h onwards).To confirm that the improved proliferation was 
indeed due to the absence of Grx2, the Grx2 KO cells were transfected with a 
construct allowing the tet-inducible expression of an ectopic copy of Grx2 and 
overexpression of Grx2 was achieved using the same procedure as in section 
3.6. Grx2 KO cells displayed a significant growth advantage compared to WT 
cells (between 44 h and 110 h) as mentioned above, whereas the Grx2 KO 
clone expressing an ectopic copy of Grx2 proliferated like WT cells (Figure 
30A). The results confirmed that the growth advantage observed in the Grx2 
KO clone was indeed due to the absence of the protein, suggesting that Grx2, 
like Grx1, may play a role in the proliferation control of bloodstream parasites 
at elevated temperatures. The average multiplication times during different 22 
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h time periods (as in section 3.6) for WT and Grx2 KO clones (- tet) are shown 
in Figure 30B. Similar to the phenotypes seen in section 3.6, 
immunofluorescence results of DAPI-stained WT and Grx2 KO cells grown at 39 
oC till time point 66 h showed that Grx2 KO cells had also more normal cells 
with one kinetoplast and one nucleus as compared to WT cells. The number of 
parasites with at least two kinetoplasts and two nuclei were also lower in the 
Grx2 KO cells compared to WT cells. The number of cells which had lost 
kinetoplast or with one kinetoplast and two nuclei were similar for both 
clones. The results as percentages of total population are shown in the table in 
Figure 30D.The results showed that Grx2 KO clones prevented the formation of 
cells with least two kinetoplasts and 2 nuclei compared to WT cells when 
grown at 39 oC, thereby confirming their better growth at 39 oC than the WT 
cells. Compared to results in section 3.6, Grx2 KO cells prevented the 
formation of the “multiple cells” better than Grx1 KO cells at 39 oC. 
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Figure 30. Proliferation of bloodstream T. brucei cell lines at 39 oC. (A) WT cells as well as a 
Grx2 KO and Grx2 KO clone expressing Grx2 (+/- 100 ng/ml tet) were cultured at 39 oC. WT 
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cells were also cultured in presence of tet as control. The cells had an initial density of 2 x 
105 cells/ml in 5 ml of 39 oC pre-warmed HMI-9 medium. After every 22 h, living cells were 
counted and the culture was diluted to the initial cell density.(A) top, representative graph 
showing the proliferation at 39 oC as a percentage to the starting cell density for the 
different cell lines. There was a significant difference in the proliferation between WT and 
Grx2 KO cells from time point 44 h onwards,  indicated by * (p value < 0.05, calculated using 
Microsoft Excel student’s unpaired t-test with equal variance). bottom, Cumulative cell 
density for the different cell lines. The experiment was done three times. The mean ± 
standard deviation is depicted. (B) Average multiplication time of WT and Grx2 KO cells at 
the indicated 22 h intervals.*,time points with a significant difference between the Grx2 KO 
and WT cells. The results are the mean ± standard deviation of three independent 
experiments. (C) Western blot analysis against Grx2. Total lysates from 3 x 10 7 cells were 
loaded on a 14 % SDS gel and subjected to Western blot analysis using anti-Grx2 antibodies 
(1:100).  1 – WT cells, 2  - Grx2 KO cells, 3 and 4 - Grx2 KO cells expressing an ectopic copy of 
wildtype Grx2 grown in the absence and presence of 100 ng/ml tet, respectively. 2 and 5 ng 
recombinant Grx2 were also loaded on the gel. 
(D) Immunofluorescence analysis. WT and Grx2 KO cells grown at 39 oC (without tet) were 
harvested after 66 h and subjected to immunofluorescence analysis. DAPI, staining of the 
kinetoplast (K, smaller dots) and nucleus (N, large dots). Phase, phase contrast pictures 
(scale bar:10 µm). At least 200 parasites for each cell line displaying one of the few different 
phenotypes are quantified. The percentages of the cells in two different experiments are 
given in the table (right). 
 
3.12 Both grx2 alleles could be deleted in Grx1 KO 
bloodstream cells 
Deletion of both grx2 alleles was attempted in bloodstream Grx1 KO cells using 
the same procedure mentioned in section 2.2.12. 
PCR analyses using the primer combination above each graph and expected 
sizes in brackets confirmed the deletion of both grx2 alleles in Grx1 KO 
bloodstream cells (Figures 31 A and B) to generate Grx1KO/Grx2 KO. 
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Figure 31. Generation of bloodstream Grx1 KO/Grx2 KO cell lines. (A) PCR analyses using 
the indicated primer combinations with the expected sizes in brackets confirmed the 
insertion of the two resistance genes in the grx2 locus in the Grx1 KO bloodstream cells. 
B 
A 
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(B)Primer combinations that distinguish the authentic grx2 gene from ectopic grx2 gene 
showed that both grx2 alleles were replaced. WT DNA served as control. 1-clone B2(1:10), 
2-clone B6(1:10), 3-clone A3 (1:20) and 4-clone D2(1:10). 
 
3.13 Redox states of glutaredoxins 
 
3.13.1 All three cysteines of recombinant Grx1 can be modified by AMS and 
NEM 
To determine the redox state of Grx1 in the intact parasite, I first studied the 
reaction of the cysteine residues in the recombinant protein. Alkylation of one 
cysteine residue by AMS adds about 500 Da to a protein and thus causes a 
mobility shift which can be analysed by SDS-PAGE and/or immunoblotting (Ahn 
and Thiele, 2003). Grx1 possesses three cysteines, namely the redox active 
Cys21 and Cys24, as well as Cys78. Modification of all three cysteines should 
thus result in a mass increase of about 1500 Da as compared to the unmodified 
protein. To facilitate distinction of the protein species, a 16 % SDS gel was used 
and the protein bands were visualized by silver-staining. Treatment of 
recombinant Grx1 with AMS resulted in a minor protein fraction that displayed 
a mobility shift of about 500 Da (Figure 32, lane 2 in comparison to lane 1). This 
is probably due to modification of Cys78 whereas Cys21 and Cys24 form an 
intramolecular disulfide bridge in the stored recombinant protein. When first 
reducing the protein with DTT and then treating it with AMS, all three 
cysteines were labelled as revealed by a mobility shift of about 1500 Da (Figure 
32, lane 3). Treatment of pre-reduced Grx1 with NEM did not result in any 
mobility shift as expected (lane 4). NEM efficiently blocked the cysteines since 
there was no mobility shift when the protein was subsequently treated with 
AMS (lane 5). This experiment showed that all three cysteines could be labeled 
with NEM and AMS under non-denaturing conditions and the method should 
be suitable for respective studies in the intact cell. 
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Figure 32. SDS-PAGE and silver-staining of recombinant Grx1 alkylated by NEM or AMS. 
500 ng of modified or unmodified protein was loaded per lane of a 16 % gel and subjected 
to SDS-PAGE under reducing conditions. lane 1, untreated Grx1 (10.8 kDa). lane 2, Grx1 
reacted with AMS. lane 3, Grx1  treated with DTT and subsequently excess AMS. lane 4, 
Grx1 treated with DTT and then with NEM. lane 5, Grx1 treated with DTT, followed by NEM  
and subsequently AMS. For details see Materials and Methods section 2.2.16. 
 
3.13.2 In bloodstream T. brucei, Grx1 is in the fully reduced state 
Wildtype bloodstream cells in logarithmic phase were harvested, proteins 
precipitated and free cysteine residues were blocked with AMS or NEM as 
described under Materials and Methods. The total protein extracts and 
recombinant Grx1 samples (as controls, see also Figure 32) were subjected to 
Western blot analyses using the anti-Grx1 antibodies (Figure 33).The untreated 
extract displayed a single protein band for Grx1 at the expected size of 10.8 
kDa (lane 1, Figure 33). In extracts treated with AMS, Grx1 was shifted by 
about 1500 Da (lane 2), revealing that all three cysteines had been labeled. 
Treatment of the extract with NEM did not result in any mobility shift (lane 3). 
Reacting the protein extract firstly with NEM and then again with AMS also did 
74 
 
not show a mobility shift (lane 4) as compared to the untreated control. The 
upper bands in the samples of recombinant protein are most probably due to 
covalent dimers. These data clearly showed that under cellular conditions all 
three cysteines of Grx1 occur in the reduced state.    
         
 
Figure 33. Western blot analyses of bloodstream T. brucei and recombinant Grx1 treated 
with alkylating agents. WT cells were harvested and the proteins were precipitated by TCA. 
After re-dissolving, free thiols were labeled with AMS and/or NEM. The samples were 
subjected to SDS-PAGE under reducing conditions followed by Western blotting using anti-
Grx1 antibodies (1:800). The extract of 3 x 106 cells was loaded per lane. lane 1,  TCA pellet 
dissolved in buffer. lane 2, TCA pellet dissolved in buffer containing 30 mM AMS.  lane 3, 
TCA pellet dissolved in buffer containing 20 mM NEM. lane 4, TCA pellet first treated with 
20 mM NEM followed by 30 mM AMS. lanes 5-10, recombinant Grx1. lane 5, untreated 
Grx1. lane 6, Grx1 treated with 30 mM AMS. lane 7, Grx1 first reduced by DTT and then 
reacted with AMS.  lane 8, reduced Grx1 reacted with 20 mM NEM. lane 9,  reduced Grx1 
labelled with NEM followed by AMS treatment. For details see section 2.2.16.  
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3.13.3 Determination of the in vivo redox state of Grx1 in bloodstream form 
parasites under normal and oxidizing conditions 
As described above, under normal culture conditions, Grx1 is in the fully 
reduced state. Upon diamide treatment of bloodstream cells, Grx1 forms an 
active site disulfide bridge, but not a covalent dimer as it is observed for the 
recombinant protein (Figure 33). Upon diamide treatment, Cys78 is still 
available for reaction with AMS as shown by the 500 Da shift (Figure 34, lane 
3). Grx1 oxidized by diamide treatment of the parasites is fully reduced within 
5 min incubation in normal medium at 37 oC (lane 4). This was confirmed by 
alkylation of the three cysteines by AMS (lane 5). 
 
 
 
 
 
 
 
 
 
 
Figure 34. Western blot analyses of bloodstream T. brucei Grx1 under normal and 
oxidizing conditions. Protein extracts from lane 1, untreated cells (i). lane 2, untreated cells, 
reacted with 30 mM AMS resulting in a mobility shift of Grx1 of about 1500 Da (ii). lane 3, 
cells treated with 3 mM diamide for 5 min, reacted with AMS (iii). lane 4, cells treated with 3 
mM diamide and subsequently incubated in HMI-9 medium (iv). lane 5, cells treated with 3 
mM diamide, incubated in HMI-9 medium and then treated with AMS (v). i – v refers to the 
conditions outlined in the Materials and Methods section 2.2.16. Cell extracts of 5 x 106 cells 
were loaded per lane on a 16 % gel under non-reducing conditions and subjected to 
Western blot analysis with the anti-Grx1 antibodies (1:800). 
 
3.13.4 In procyclic T. brucei, Grx2 is in the fully reduced state  
In procyclic cells grown under standard conditions, Grx2 is in the fully reduced 
state and rapidly recovers from oxidative stress resulting in a mobility shift 
upon labelling of cell extracts with AMS (Figure 35, lane 2) from cells that were 
cultured normally. Upon diamide treatment, no cysteines could be labelled 
with AMS (Figure 35, lane 4), as there was no mobility shift compared to 
1 2 3 4 5 
10 
15 
kD
a 
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unlabeled Grx2 (lane 3). Most probably the two active-site cysteines make an 
intradisulfide bridge upon diamide treatment. Upon removal of diamide stress, 
Grx2 was in fully reduced state as two cysteines could be labelled with AMS 
(lane 6). 
 
Figure 35. Western blot analyses of the Grx2 in procyclic T. brucei under normal and stress 
conditions. (1 - 6 are lane numbers). lane 1, untreated cells (i)., lane 2, untreated cells, 
reacted with 30 mM AMS (ii)., lane 3, cells treated with 3 mM diamide for 5 min(iii).,  lane 4, 
cells treated with 3 mM diamide for 5 min, reacted with AMS (iv)., lane 5, cells treated with 
3 mM diamide and subsequently incubated in HMI-9 medium (v). lane 6, cells treated with 3 
mM diamide, incubated in HMI-9 medium and then treated with AMS (vi). i – vi refers to the 
conditions outlined in the Materials and Methods section 2.2.16. Cell extracts of 1 x 107 cells 
were loaded per lane on a 16 % gel under non-reducing conditions and subjected to 
Western blot analysis with the anti-Grx2 antibodies (1:200). Weak bands in lanes 4 and 6 
might have been caused by loss of extracts during washing after TCA precipitation. 
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4 Discussion 
4.1 Role of glutaredoxins under various stressors 
Bloodstream and procyclic cells lacking Grx1 were viable under culture 
conditions. This was also reported in yeast where cells lacking grx1, grx2 or 
both grx1 and grx2 were viable and the glutaredoxins were dispensable under 
culture conditions (Luikenhuis et al., 1998). Glutaredoxins in various organisms 
have been reported to protect cells against damage caused by oxidizing agents 
such as hydrogen peroxide and diamide. For example, human Grx2 (Wu et al., 
2010) and E. coli Grx2 (Fernandes and Holmgren, 2004) have been shown to 
protect cells against hydrogen peroxide-induced oxidative stress. Also yeast 
Saccharomyces cerevisiae dithiol grx2 mutants or grx1grx2 double mutants 
were sensitive to hydrogen peroxide compared to WT strains (Luikenhuis et al., 
1998). Recombinant T. brucei Grx1 was shown to coordinate an iron-sulfur 
cluster (Ceylan et al., 2010). This led me to study whether the absence of Grx1 
affects the sensitivity of parasites towards exogenous iron. There was no 
difference in the proliferation between WT and Grx1 KO cell lines when iron 
was used as stress as the cells proliferated like untreated controls. The 
proliferation defect observed in both WT and Grx1 KO parasites when 
deferoxamine was used as a stressor, was probably due to an impaired 
biosynthesis of iron-dependent enzymes like ribonucleotide reductase, 
superoxide dismutase, and alternative oxidase (Breidbach et al., 2002). In the 
cyanobacterium Synechocystis sp. PCC 6803, the dithiolic GrxA was reported to 
protect the cell against heat shock (Sanchez-Riego et al., 2013) and also ectopic 
expression of AtGrxS17 (a monothiol Grx) was reported to increase 
thermotolerance in tomato plants (Wu et al., 2012). I investigated a respective 
role of Grx1 in the KO cells compared to WT cells and there was no difference 
in recovery after heat shock between the two cell lines. 
Though Grx1 was not found to play role in protecting both T. brucei 
bloodstream and procyclic cells from the stresses used in our experiments, it 
will be worthy to investigate the proliferation of the parasites under other 
forms of stresses such as menadione or osmotic stress. Bloodstream cells 
lacking Grx2 are viable and the protein is dispensable under culture conditions. 
T. cruzi epimastigotes overexpressing Grx2, a cytosolic protein which has about 
80 % identity to T. brucei Grx2, were more viable than wildtype cells under 
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oxidative stress caused by hydrogen peroxide (Marquez et al. 2014). 
Investigations need to be done on the proliferation of the bloodstream cells 
lacking Grx2 under various stress conditions compared to wildtype cells. 
However, it is not possible to investigate the effect of different stresses in 
procyclic cells compared to WT parasites since cells lacking Grx2  could only be 
obtained in the presence of a tet-inducible ectopic copy of Grx2 (wildtype or 
Grx2C34S mutant) and had  leaky expression when tet was removed, 
consistent with an essential role in procyclic cells.  
 
4.2 Glutathionylated Grx1 has decreased activity in HED 
assay 
The third non-active site cysteine of Grx1 is conserved in the Grx1 sequences 
of Leishmania major (Ceylan et al., 2010), human and T. vivax 
(TvY486_1101340) as well as E. coli Grx3 which may suggest a putative 
regulatory function in the parasite oxidoreductases. Protein glutathionylation 
can result in several effects that include inhibition of a protein function. 
Examples include transcription factors like Jun and NF-kB which are inhibited 
by glutathionylation (Ghezzi, 2005). The activity of GAPDH was inhibited upon 
glutathionlyation during ischemia and reperfusion (Eaton et al., 2002). S-
glutathionylation of aldose reductase 2 (ALR2) resulted in decreased activity of 
the enzyme (Cappiello et al., 2001). It was shown that glutathionlyation of Cys 
95 inhibits HIV protease’s activity whilst glutathionylation of Cys 67 stabilised 
the enzyme (Dalle-Donne et al., 2007). Our in vitro results showed that the 
non-active site cysteine (Cys78) of T. brucei Grx1 can be glutathionylated. 
Glutathionylated Grx1 (glut-Grx1) had an activity that was three fold lower 
compared to the wildtype protein in the HED assay. The Km value for glut-Grx1 
was also about three fold lower as compared to that of Grx1 resulting in an 
overall same kcat/Km values between the two protein species of Grx1. These 
results showed that glutathionylation of the non-active site cysteine might 
have a regulatory role in T. brucei. The decrease in activity after 
glutathionylation at non-active site cysteine was also mentioned for bacterial 
Grx3 by Lind et al., 1998. 
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4.3 Redox state of Grx1 in bloodstream Trypanosoma brucei 
and of Grx2 in procyclic cells 
As shown in this thesis, Grx1 in bloodstream parasites is in the fully reduced 
state under normal culture conditions. Upon diamide treatment, the protein 
forms an intramolecular disulfide bridge in the active site. In contrast, 
recombinant Grx1 forms a dimer upon storage which indicates that dimer 
formation of Grx1 is something artificial that only occurs in vitro. The non-
active site cysteine of Grx1 could still be labelled with AMS after diamide 
treatment. Upon removal of the diamide stress, Grx1 was again in the fully 
reduced state within 5 min, revealing the quick regeneration under normal 
cellular conditions.  
The redox state of Grx2 under normal and oxidizing conditions was 
investigated in procyclic cells.Grx2 has only two cysteines which are in the 
active site. As in the case of Grx1 in bloodstream cells, Grx2 is in the fully 
reduced state in procyclic cells under culture conditions and forms an 
intradisulfide bridge in the active site upon oxidative stress. It is also fully 
reduced within 5 min after removal of diamide as there was a mobility shift 
when cell extracts were labelled with AMS compared to unlabeled controls. 
The redox state of Grx2 in bloodstream cells was not investigated since Grx2 is 
very difficult to detect by Western blot analysis in these cells due to very low 
protein levels (Ceylan et al., 2010). 
 
4.4 Bloodstream parasites lacking Grx1 or Grx2 proliferate 
better at 39 °C than wildtype cells 
My investigations showed that bloodstream parasites lacking either Grx1 or 
Grx2 have a proliferation advantage at 39 oC as compared to wildtype cells. It 
might be possible that at least one of the proteins that function in 
temperature-sensing in bloodstream trypanosomes might have been inhibited 
due to the absence of either glutaredoxin, thereby allowing the cells lacking 
either glutaredoxins to have a proliferation advantage at 39 oC compared to 
wildtype cells.Grx1 is located in the cytosol whereas Grx2 occurs in the 
mitochondrion, probably in the intermembrane space (Ceylan et al., 2010). 
These two glutaredoxins seem to have  a coordinated function in this regard 
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though they are located in different compartments with Grx2 playing a major 
role. The two glutaredoxins cannot be said to have an overlapping function 
since I showed that there was no upregulation of Grx1 in Grx2 KO clone and 
also that there was no upregulation of Grx2 in a Grx1 KO clone. Furthermore, 
there is a very low level of Grx2 in bloodstream parasites (Ceylan et al., 2010). 
A likely modification of any candidate protein in this pathway maybe 
glutathionylation since it was shown that both Grx1 and Grx2 had 
deglutathionylation activities in vitro, though the former had higher activity 
(Ceylan et al., 2010).  
 
A cytosolic Trypanosoma brucei Hsp70.c. was shown to be upregulated upon 
heat stress in bloodstream parasite (Burger et al., 2014). ZC3H11, a zinc finger 
protein that binds and stabilize the 3`-untranslated region of mRNAs of heat-
shock proteins in T. brucei  was shown to stabilise the mRNA of bloodstream 
Hsp70 (Droll et al., 2013). It is possible that the absence of Grx1 or Grx2 
increases the stabilizing effect of ZC3H11 on Hsp70 mRNA, thereby having the 
parasites lacking either glutaredoxins having a proliferation advantage at 39 oC 
than wildtype cells. 
 
Cell division of trypanosomes occurs by binary fission with two distinct phases 
that must be coordinated whereby the initial process involves the S-phase of 
the mitochondrial DNA before the nuclear DNA is replicated (Vaughan and 
Gull, 2008). Immunofluorescence analysis with DAPI of the parasites cultured 
at 39 oC till 66 h revealed that the wildtype cells had significantly more 
difficulties in dividing as compared to either the cells lacking Grx1 or Grx2. The 
populations of parasites lacking either Grx1 or Grx2 contained more normal 
cells with 1 nuclei and 1 kinetoplast (1K1N) and less parasites that had at least 
2 kinetoplast and 2 nuclei (≥2K2N) as compared to wildtype cells at 39 oC. 
These results indicated that bloodstream T. brucei have severe problems in 
starting cytokinesis at 39 °C, a phenotype less pronounced in the Grx1 or Grx2 
deficit cells. Several assumptions can be made regarding the observed 
phenotypes including the following. 
 
Trypanosome receptor for activated C kinase (TRACK) is required for the 
initiation of cytokinesis in bloodstream parasites (Rothberg et al., 2006). RNAi 
81 
 
against TRACK in bloodstream cells results in growth inhibition. The number of 
cells with 1N1K (1 nuclei and 1 kinetoplast) decreases whilst those with 2N2K 
increases with time, revealing problems in cytokinesis (Rothberg et al., 2006). 
A very similar phenotype was observed for wildtype bloodstream cells when 
cultured at 39 °C which was attenuated in parasites lacking either Grx1 or 
Grx2. Thus one may speculate that either the parasite glutaredoxins are 
negatively involved in the signaling pathway of TRACK or that they directly 
interact with TRACK. When either or both Grxs are absent, the TRACK is 
modified in such a way that it retains a comparatively high cytokinesis at 39 oC, 
resulting in cells that proliferate better than the wildtype cells. TRACK is 
localized in the cytosol and in perinuclear region. TRACK has got nine cysteines 
and five of them are conserved in the receptor for activated C kinases of 
Leishmania major (LACK) and Homo sapiens (RACK1). It might be possible that 
some of the cysteines from TRACK are prone to glutathionlyation in the 
absence of either Grxs, resulting in stability and initiating cytokinesis at 39 oC in 
bloodstream cells.   
  
The DAPI staining also revealed that in all three cell lines (WT, Grx1 KO and 
Grx2 KO), there was almost an identical number of parasites that had (i) no 
kinetoplast and one nuclei (0 K & 1N) and (ii) one  kinetoplast and two nuclei 
(1K & 2N). Failure of kinetoplast segregation can result in trypanosomes that 
have no kinetoplast or a kinetoplast and two nuclei (Liu et al., 2009). These 
phenotypes are probably a general consequence caused by the high 
temperature and cannot be attributed to the lack of Grx1 and Grx2. 
 
Grx2 mutants in yeast were reported to have higher tolerance to cadmium (a 
toxic heavy metal) exposure as compared to wildtype cells. However this was 
found to be a temporary putative advantage since the mutants had higher 
mutagenic rates as compared to wildtype cells (Gomes et al., 2008). The 
growth advantage at 39 °C of the T. brucei Grx1 and Grx2 KO mutants might 
also be only a temporary benefit. Wildtype cells might not want to keep 
dividing at the elevated temperature where they will not survive in the long 
term by decreasing proliferation at the level of cytokinesis at 39 °C. The 
bloodstream cells lacking Grx1 or Grx2 displayed a significantly higher number 
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of normal wildtype-like phenotype. However, this might be related with a 
higher mutagenic rate. 
 
T. cruzi epimastigotes overexpressing Grx2 were found to go under apoptosis 
more than wildtype when stimulated with human fresh serum (Marquez et al., 
2014). This showed that Grx2 was pro-apoptotic in T. cruzi. The Grx-type 
protein might also play a pro-apoptotic role in bloodstream parasites at 39 oC 
resulting in fewer number of total parasites for wildtype cells than for those 
parasites lacking Grx2. Parasites lacking Grx2 retained the highest proliferation 
amongst the three cell lines studied which might be due to inadequate 
apoptosis in these cells at 39 °C. This can be investigated in future by checking 
for apoptosis markers like cytochrome c release (Esseiva et al., 2004), DNA 
degradation and phosphatidylserine exposure (Tsuda et al., 2005) in wildtype 
cells compared to the parasites either lacking Grx2 when grown at 39 oC. 
 
There might be several proteins modified in the same signaling pathway 
involving Grx1 and/or Grx2 in bloodstream cells. Since it is not yet clear what 
the targets of the two dithiol Grxs are, the actual roles of the oxidoreductases 
at 39 °C remain to be elucidated. It will also be highly likely that the most 
affected protein of this signaling pathway is in the mitochondrion since cells 
lacking Grx2 retained the highest proliferation rate. 
Though the two dithiol glutaredoxins are located in different compartments, it 
seems that they have a coordinated role at 39 °C in bloodstream parasites. To 
investigate on this, bloodstream parasite lacking both Grx1 and Grx2 were 
generated and are still to be characterized upon culturing at 39 °C compared to 
wildtype cells. At least the phenotype observed for the bloodstream parasites 
lacking Grx2 should be observed in the parasites lacking both Grx1 and Grx2. 
Since the wildtype-like proliferation was obtained upon expressing the 
respective ectopic copies of the Grxs in the KO backgrounds, it should also be 
investigated if these Grxs have redox function at 39 oC by expressing ectopic 
non-redox mutants in KO backgrounds and investigate them upon culturing at 
39 oC compared to wildtype cells. 
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4.5 Grx2 may be involved in deglutathionylation reactions in 
procyclic cells 
T. brucei procyclic cells lacking Grx2 were fully viable when they express an 
ectopic copy of either wildtype Grx2 or Grx2C34S mutant. Recombinant 
Grx2C34S showed 35 % activity of wildtype Grx2 in the HED assay. Similar 
results were obtained for other recombinant proteins lacking the C-terminal 
cysteines. The C34S mutant of Trypanosoma cruzi Grx2 catalyzes the reduction 
of GSSG with the same kinetic constants as wildtype Grx2, showing the 
cysteine at position 34 is not essential for this reaction (Marquez et al., 2014). 
The respective cysteine mutant of human Grx2, Grx2C40S, catalyses the 
reduction of GSH-mixed disulfides in the HED assay with 26 % catalytic 
efficiency of the wildtype protein (Johansson et al., 2004).The yeast Grx2 
mutant (C30S) has 30 % of the specific activity in the HED assay compared to 
wildtype Grx2 (Discola et al., 2009). The corresponding E. coli Grx1 cysteine 
mutant (C14S) shows 38 % of the activity of the wildtype protein in the HED 
assay (Bushweller et al., 1992). 
Remarkably, Leishmania Grx2 which has about 80 % identity to T. brucei Grx2, 
is a monothiol since it has a serine residue instead of the second cysteine in 
the active site (Ceylan et al., 2010). Taken together, these data support the 
results of my in vitro assays that the C-terminal cysteine was dispensable in T. 
brucei recombinant Grx2 in a HED assay, though the activity was lower and 
also why the procyclic cells could survive with an ectopic copy of Grx2C34S. 
Thus one may speculate that Grx2 in procyclic cells might be involved in 
essential (de)glutathionylation reactions. Clearly this role is not conserved in 
bloodstream parasites since Grx2 was dispensable under culture conditions 
and its absence even conferred a proliferation advantage at elevated 
temperature. 
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6 Supplementary Results 
 
Sequences 
pHD1747-grx1-KO cassette 
CTCGAGGTAACTGCATCACGCACATCAGTGTTCTGTACAACGACGCGAATCCACAAATGCCT
CTGGTACATGCCGTATGCTACCATTTGTATTCTTCCTACGTGTGTACTTTTTTCATTACCTT
CCTTTTATTTATTTTTTTAAATTCTGAAATGTTTTTATGTGATGTGCCCATATAAATGCACC
GGAACCAAAAAAAAAAAAACACAAAGAATCAAGAAGAAACACAAACATTTAGCACTTTCCCA
CCTCGTTTTTATTCACTTACAATACACCTTGAAGTGAATAAAACTAAGGTTACTCTGTAGAG
TGGGACAAAAACTTTGTTATATATATATATATATATATTTATTTATTTATTTATCTTGTATT
TTGTCCCCAACACGTGGTATCAAGCTTGATAGCTTACCATGACCGAGTACAAGCCCACGGTG
CGCCTCGCCACCCGCGACGACGTCCCCAGGGCCGTACGCACCCTCGCCGCCGCGTTCGCCGA
CTACCCCGCCACGCGCCACACCGTCGATCCAGACCGCCACATCGAGCGGGTCACCGAGCTGC
AAGAACTCTTCCTCACGCGCGTCGGGCTCGACATCGGCAAGGTGTGGGTCGCGGACGACGGC
GCAGCAGTGGCGGTCTGGACCACGCCGGAGAGCGTCGAAGCGGGGGCGGTGTTCGCCGAGAT
CGGCCCGCGCATGGCCGAGTTGAGCGGTTCCCGGCTGGCCGCGCAGCAACAGATGGAAGGCC
TCCTGGCGCCGCACCGGCCCAAGGAGCCCGCGTGGTTCCTGGCCACCGTCGGTGTCTCGCCC
GACCACCAGGGCAAGGGTCTGGGCAGCGCCGTCGTGCTCCCCGGAGTGGAGGCGGCCGAGCG
CGCCGGGGTGCCCGCCTTCCTGGAGACCTCCGCGCCCCGCAACCTCCCCTTCTACGAGCGGC
TCGGCTTCACCGTCACCGCCGACGTCGAGGTGCCCGAAGGACCGCGCACCTGGTGCATGACC
CGCAAGCCCGGTGCCTGAATCGAATTCTAGTGCCAAACGAGAGGTGTTTGCATATGTTGAGG
GGGTAAACTACACACCCTTCCTTTATATACATCTCCTTCATCCTTCACTTGATCGCTTTCAT
TTTTTTTATATTTTTGTTCCTGCTTATATTAGGGGTTATAATGCATTATGCATGATGTGTTC
TGCTCATTTCATAACGAGGGAAGGGAAAACGGAAACGGAAATGCAAGAACGGGAGAGAGTAG
GAGCGAGTGAACTGACATCAATTCAATCGGGGGAAGTGTTTAAAAACACCTCACCGGTATAA
CTTCCCCTATTGATACGTTACGCACGACGCTATTTCTGTTGTTGAATACTCGCGCTTTGAAG
ATCGCCTTTTAGCACGCGGCCG 
CTCGAG  – XhoI restriction site 
AAGCTT  – HindIII restriction site 
GAATTC  – EcoRI restriction site 
GCGGCCG – NotI restriction site 
ATG and TGA are the start and stop codon, respectively, of the puromycin 
resistance gene. The 5’- and 3’- untranslated regions of the grx1 gene are given 
in italics. 
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pHD1748-grx1-KO cassette 
CTCGAGGTAACTGCATCACGCACATCAGTGTTCTGTACAACGACGCGAATCCACAAATGCCT
CTGGTACATGCCGTATGCTACCATTTGTATTCTTCCTACGTGTGTACTTTTTTCATTACCTT
CCTTTTATTTATTTTTTTAAATTCTGAAATGTTTTTATGTGATGTGCCCATATAAATGCACC
GGAACCAAAAAAAAAAAAACACAAAGAATCAAGAAGAAACACAAACATTTAGCACTTTCCCA
CCTCGTTTTTATTCACTTACAATACACCTTGAAGTGAATAAAACTAAGGTTACTCTGTAGAG
TGGGACAAAAACTTTGTTATATATATATATATATATTTATTTATTTATTTATCTTGTATTTT
GTCCCCAACACGTGGTATCAAGCTTGATCATGGCCAAGCCTTTGTCTCAAGAAGAATCCACC
CTCATTGAAAGAGCAACGGCTACAATCAACAGCATCCCCATCTCTGAAGACTACAGCGTCGC
CAGCGCAGCTCTCTCTAGCGACGGCCGCATCTTCACTGGTGTCAATGTATATCATTTTACTG
GGGGACCTTGTGCAGAACTCGTGGTGCTGGGCACTGCTGCTGCTGCGGCAGCTGGCAACCTG
ACTTGTATCGTCGCGATCGGAAATGAGAACAGGGGCATCTTGAGCCCCTGCGGACGGTGCCG
ACAGGTGCTTCTCGATCTGCATCCTGGGTCAAAGCCATAGTGAAGGACAGTGATGGACAGCC
GACGGCAGTTGGGATTCGTGAATTGCTGCCCTCTGGTTATGTGTGGGAGGGCTAAGCACATC
GAATTCTAGTGCCAAACGAGAGGTGTTTGCATATGTTGAGGGGGTAAACTACACACCCTTCC
TTTATATACATCTCCTTCATCCTTCACTTGATCGCTTTCATTTTTTTTATATTTTTGTTCCT
GCTTATATTAGGGGTTATAATGCATTATGCATGATGTGTTCTGCTCATTTCATACACGAGGG
AAGGGAAAACGGAAACGGAAATGCAAGAACGGGAGAGAGTAGGAGCGAGTGAACTGACATCA
ATTCAATCGGGGGAAGTGTTTAAAAACACCTCACCGGTATAACTTCCCCTATTGATACGTTA
CGCACGACGCTATTTCTGTTGTTGAATACTCGCGCTTTGAAGATCGCCTTTAGCACGCGGCC
GC 
 
CTCGAG  – XhoI restriction site 
AAGCTT  – Hind III site 
GAATTC  – EcoRI  site 
GCGGCCG – NotI  site 
ATG and TAA are the start and stop codon, respectively, of the blasticidin 
resistance gene. The 5’- and 3’- untranslated regions of the grx1 gene are given 
in italics. 
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pHD1747-grx2-KO cassette 
CTCGAGCTCTTTTACTAAGGTAGAATTTTTTTTTTAATAAAATAGTAAAAGGAACTACTAAT
AACGGAGTTCCAATCCTTTTCGGCCAGCTTTAACGACACTTCTGCATAAGGGGAGGGGGGGA
AGTTATTTTAAAAAAAAAAGTAAAGAAGTTGTGGAGTTCAAGTGCGCTGGTATCAAATACAT
AAGTCACGTGATTGCGTCCAAAGAAAACCAGTGAAGCTGGATTTATTAACGTCAGGCAGTTC
CAAACAAACACAAATAAGATTTAGTATAAGGTTACACATATTTAGTTGTTGATTTACATATA
TAGTTGACTTGTTTGCTTTATTTTGTTCTATTTTATTTTATTCTATTTTTTTTTTTGTACGT
TGCTGTGAGGAAGCTTgatagcttaccATGACCGAGTACAAGCCCACGGTGCGCCTCGCCAC
CCGCGACGACGTCCCCAGGGCCGTACGCACCCTCGCCGCCGCGTTCGCCGACTACCCCGCCA
CGCGCCACACCGTCGATCCAGACCGCCACATCGAGCGGGTCACCGAGCTGCAAGAACTCTTC
CTCACGCGCGTCGGGCTCGACATCGGCAAGGTGTGGGTCGCGGACGACGGCGCAGCAGTGGC
GGTCTGGACCACGCCGGAGAGCGTCGAAGCGGGGGCGGTGTTCGCCGAGATCGGCCCGCGCA
TGGCCGAGTTGAGCGGTTCCCGGCTGGCCGCGCAGCAACAGATGGAAGGCCTCCTGGCGCCG
CACCGGCCCAAGGAGCCCGCGTGGTTCCTGGCCACCGTCGGTGTCTCGCCCGACCACCAGGG
CAAGGGTCTGGGCAGCGCCGTCGTGCTCCCCGGAGTGGAGGCGGCCGAGCGCGCCGGGGTGC
CCGCCTTCCTGGAGACCTCCGCGCCCCGCAACCTCCCCTTCTACGAGCGGCTCGGCTTCACC
GTCACCGCCGACGTCGAGGTGCCCGAAGGACCGCGCACCTGGTGCATGACCCGCAAGCCCGG
TGCCTGAatcGAATTCGGGGCTGAAGAGGTAATTATTGTTTATGTATTGTGAGCATAGGCGT
AACGAAATATATTTATGTGTATGTTCACTTCGATGGAGCGTACAGCTGTAATGTTTAATTGT
CTCATTTTGAGACGGGCAGTGGTCATTTGGTTTTTTTTGTTGTTATTGTTGTTGTTGTTTTT
TTTTTCTTATGTTTTTTTTTTGTTTCATCTGTCACCACTTTCTTTCTTTCTTTCTTTCATCG
TTCCATAGAAATTTGAACGATGATGTGGAAAGGGAGGATTGTGTGGAGAAAATGAGGCACAC
GAACATGGAAGTTTGTTAATAGGTATTCATACTCACACATGTATTTGTATGGCGTGCACATC
TCGCTGATTCTCTGTTTTGGTTTTATTTGTTGTTGTATGCTGCTCGGCGGCCGC 
 
CTCGAG  – XhoI restriction site 
AAGCTT  – Hind III site 
GAATTC  – EcoRI  site 
GCGGCCG – NotI site 
ATG and TGA are the start and stop codon, respectively, of the puromycin 
resistance gene. The 5’- and 3’- untranslated regions of the grx2 gene are given 
in italics. 
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pHD1748(neo)-grx2-KO cassette 
CTCGAGCTCTTTTACTAAGGTAGAATTTTTTTTTTAATAAAATAGTAAAAGGAACTACTAAT
AACGGAGTTCCAATCCTTTTCGGCCAGCTTTAACGACACTTCTGCATAAGGGGAGGGGGGGA
AGTTATTTTAAAAAAAAAAGTAAAGAAGTTGTGGAGTTCAAGTGCGCTGGTATCAAATACAT
AAGTCACGTGATTGCGTCCAAAGAAAACCAGTGAAGCTGGATTTATTAACGTCAGGCAGTTC
CAAACAAACACAAATAAGATTTAGTATAAGGTTACACATATTTAGTTGTTGATTTACATATA
TAGTTGACTTGTTTGCTTTATTTTGTTCTATTTTATTTTATTCTATTTTTTTTTTTGTACGT
TGCTGTGAGGAAGCTTATGGTGGAACAAgatggattgcacgcaggttctcCGGCCGCTTGGG
TGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTG
TTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCT
GAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCG
CAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCG
GGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGC
AATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATC
GCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAA
GAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGG
CGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCC
GCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCG
TTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCT
TTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCT
TCTGAGAATTCGGGGCTGAAGAGGTAATTATTGTTTATGTATTGTGAGCATAGGCGTAACGA
AATATATTTATGTGTATGTTCACTTCGATGGAGCGTACAGCTGTAATGTTTAATTGTCTCAT
TTTGAGACGGGCAGTGGTCATTTGGTTTTTTTTGTTGTTATTGTTGTTGTTGTTTTTTTTTT
CTTATGTTTTTTTTTTGTTTCATCTGTCACCACTTTCTTTCTTTCTTTCTTTCATCGTTCCA
TAGAAATTTGAACGATGATGTGGAAAGGGAGGATTGTGTGGAGAAAATGAGGCACACGAACA
TGGAAGTTTGTTAATAGGTATTCATACTCACACATGTATTTGTATGGCGTGCACATCTCGCT
GATTCTCTGTTTTGGTTTTATTTGTTGTTGTATGCTGCTCGGCGGCCG 
 
CTCGAG  – XhoI restriction site 
AAGCTT  – Hind III site 
GAATTC  – EcoRI  site 
GCGGCCG – NotI site 
ATG and TGA are the start and stop codon, respectively, of the neomycin 
resistance gene. The 5’- and 3’- untranslated regions of the grx2 gene are given 
in italics. 
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Digitonin analysis of bloodstream Grx2 KO cells expressing an 
ectopic copy of Grx2-c-myc2 
Bloodstream Grx2 KO cells expressing and ectopic copy of Grx2-c-myc2 were 
grown overnight in the presence of 1 µg/ml tet. Cells were harvested and 
subjected to digitonin lysis basically as described in Ceylan et al., 2010. The 
supernant and pellet fractions corresponding to 1.9 x 106 cells were loaded on 
a 14 % gel and subjected to Western blot analysis using the anti-Grx2 
antibodies (α-guinea pig (1:100). 
The results showed that overexpression of an ectopic copy of Grx2-c-myc2 in 
bloodstream cells resulted in the Grx2-c-myc2 being located mainly in the 
cytosol (Figure S1).
 
Figure S1. Localisation of Grx2-c-myc2 in bloodstream Grx2 KO cell line. 
Bloodstream Grx2 KO cells lines expressing an ectopic copy of Grx2 were 
cultured overnight in presence of 1 µg/ml tet. Fractions corresponding to 1.9 x 
106 cells after digitonin lysis (mg digitonin to mg protein ratios are indicated 
above each lane) were loaded on a 14 % gel and subjected to Western blot 
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analysis using anti-Grx2 antibodies. Upper blot, supernatant fractions and 
lower blot, pellet fractions. T is the total lysate (not subjected to digitonin 
fractionation) 
 
